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The Zn2+-dependent bacterial deacetylase LpxC is a promising target for the 
development of novel antibiotics. Most of the known LpxC inhibitors carry a 
hydroxamate moiety as Zn2+-binding group. However, hydroxamic acids generally 
exhibit poor pharmacokinetic properties. (S)-N-Hydroxy-2-{2-hydroxy-1-[4-
(phenylethynyl)phenyl]ethoxy}acetamide (3) is a known phenylethylene glycol 
derivative potently inhibiting LpxC with a Ki of 66 nM. In vitro experiments have 
confirmed in silico predictions that the hydroxamate moiety of 3 is indeed metabolically 
labile. In this study, several strategies were explored to replace the hydroxamate 
moiety by other Zn2+-binding groups while maintaining target activity. In total, 15 
phenylethylene glycol derivatives with diverse Zn2+-binding groups like carboxylate, 
hydrazide, carboxamide, sulfonamide, vicinal diol, thiol, thioester, and 
hydroxypyridinone moieties were prepared in divergent syntheses. However, their 
biological evaluation revealed that the replacement of the hydroxamate moiety of 3 by 






After iron, zinc is the second most abundant transition metal in all living organisms, 
including animals, plants, and microorganisms, with Zn2+-containing enzymes 
constituting the largest category of metalloproteins.1 Many of these enzymes are 
involved in biological processes also associated with the propagation of various 
diseases, like cancer, arthritis, hypertension, and bacterial infections, thus making 
them attractive targets for drug therapy.2 In the design and development of inhibitors 
of these enzymes, their metal ion cofactor has frequently been targeted by chelating 
groups.3-4 
The Zn2+-dependent bacterial deacetylase LpxC represents a promising target for 
the development of antibiotics, selectively combating Gram-negative bacteria.5 The 
enzyme, which is highly conserved among Gram-negative bacteria, is involved in the 
biosynthesis of lipid A. Lipid A is essential for growth and viability of Gram-negative 
bacteria as it constitutes the hydrophobic membrane anchor of lipopolysaccharides, 
representing the main component of the outer monolayer of the outer membrane of 
these germs.6 LpxC plays a central role in lipid A biosynthesis, catalyzing its first 
irreversible step, which in E. coli is the deacetylation of UDP-3-O-[(R)-3-
hydroxymyristoyl]-N-acetylglucosamine (1, Scheme 1).7-8 The enzyme’s catalytic Zn2+-
ion is located at the bottom of the ~20 Å deep, conical active site cleft, where it is 
coordinated by one aspartate and two histidine residues. From this active site, an 
approximately 15 Å long, hydrophobic tunnel leads outwards, which encloses the 3-O-






Scheme 1: LpxC-catalyzed deacetylation of UDP-3-O-[(R)-3-hydroxymyristoyl]-N-
acetylglucosamine (1). 
 
Various structural classes of LpxC inhibitors have been described in the patent and 
non-patent literature.5, 11 Most of the described inhibitors share common structural 
features like a Zn2+-binding group as well as a structural element addressing the 
enzyme’s hydrophobic tunnel.5, 11-12 The vast majority of the reported LpxC inhibitors 
uses a hydroxamate moiety as the Zn2+-binding group.  
Although a hydroxamate moiety is found in some approved drugs, like the histone 
deacetylase inhibitors vorinostat, panobinostat, and belinostat, the clinical 
effectiveness of hydroxamic acids is generally limited by their inadequate selectivity for 
Zn2+-ions and poor pharmacokinetics.13-18 The unfavorable pharmacokinetic properties 
of hydroxamic acids result from poor oral bioavailability as well as high clearance due 
to rapid metabolism via conjugate formation (glucuronidation and sulfation), reduction, 
and hydrolytic cleavage, the latter leading to the release of toxic hydroxylamine.19-26 
In case of numerous Zn2+-containing target enzymes, inhibitors have been 
developed which exhibit alternative Zn2+-binding groups with more favorable 
pharmacological and pharmacokinetic properties.13, 19, 24, 27-28 However, in the case of 
LpxC inhibitors, only a few inhibitors that do not contain the Zn2+-chelating 
hydroxamate moiety have been reported so far.29-37 
Recently, we have reported on a series of benzyloxyacetohydroxamic acids as 
inhibitors of LpxC, with the most potent compound, 3 (Figure 1), exhibiting promising 
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activities in the enzyme assay (IC50 = 0.48 µM, Ki = 66 nM) as well as in the performed 
disc diffusion assays (Table 1).38 Therefore, the compound should be further 
investigated. In this work, the results of in silico and in vitro experiments on the 
metabolism of hydroxamic acid 3 are reported. In addition, a systematic study of 
alternative metal binding groups is described, in which the hydroxamate moiety of 3 
was replaced by various other Zn2+-binding groups that are part of effective inhibitors 
of other Zn2+-dependent enzymes.24, 39-45 Thus a carboxylic acid, a hydrazide, several 
amides and sulfonamides, vicinal diols, a thiol, a thioester, and hydroxypyridinone 
derivatives were synthesized and tested for antibacterial activity. 
 
 





2. Results and Discussion 
2.1. Prediction of the metabolism of 3 
The susceptibility of 3 toward human cytochrome P450 (CYP)-mediated metabolism 
was investigated with FAME 2, a random forest-based predictor of sites of 
metabolism.46 FAME 2 assigned a moderate likelihood of metabolism (0.602; values 
ranging from 0 to 1, with higher values indicating higher probabilities of atoms being 
sites of metabolism) to the para-position of the terminal phenyl moiety (Figure 2). This 
is interpreted as a moderate likelihood for a hydroxylation to happen at this atom 




Figure 2: Predictions of sites of metabolism with FAME 2 and of metabolites with 
SyGMa. The circle in the center compound (parent) indicates the most likely labile 
atom position related to CYP-mediated metabolism. The numbers report the scores 
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(probabilities) assigned by FAME 2 or SyGMa. Note that scores from FAME 2 and 
SyGMa are not directly comparable. In the case of SyGMa they should primarily be 
considered as a means for ranking metabolites. 
 
The most likely human metabolites of 3 resulting from phase I and phase II metabolism 
were predicted with SyGMa.47 SyGMa assigns to all predicted metabolites an empirical 
probability score, which represents the proportion of correctly predicted metabolites of 
the training set. For 3, SyGMa predicts four metabolites with a score greater than 0.09 
(Figure 2): two glucuronic acid conjugates (4, 7) and two carboxylic acid metabolites 
(5, 6). 
 
2.2. In vitro metabolism using rat liver microsomes 
To identify the metabolically labile positions of hydroxamic acid 3 in vitro, the 
compound was incubated with NADPH (for CYP-mediated phase I metabolism) and 
UDPGA (for UGT-mediated phase II metabolism) in the presence of a suspension of 
rat liver microsomes (Figure 3).  
 
 
Figure 3: HPLC chromatogram of the incubation of 3 with a rat liver microsome 
suspension, NADPH/H+ and UDPGA. EICs: blue (m/z 486.1414±0.05), green 
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(310.1091±0.05), red (295.0991±0.05), gradient elution (HPLC method 3), MS-
detection in negative ion polarity. 
 
Furthermore, experiments with 3 and the rat liver microsome suspension alone as well 
as with the addition of only one of the cofactors have been performed. All samples 
were analyzed by LC-MS. Suggestions on the chemical structure of the formed 
metabolites were made based on their exact masses and retention times (Figure 4).  
 
 
Figure 4: Suggested structures of the observed phase I- and phase II-metabolites of 
hydroxamic acid 3. 
 
When investigating the phase I metabolism of 3, the formation of carboxylic acid 6 (3-
NH) was observed. Whereas only traces of carboxylic acid 6 were found upon 
incubation of 3 in PBS buffer pH 7.4 for 120 min, the addition of the rat liver microsome 
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suspension caused a hydrolytic cleavage of the hydroxamate moiety, irrespective of 
the absence or presence of the cofactor NADPH. 
In the performed phase II metabolism study of 3, conjugate formation yielded 
glucuronide 3+Glu, which is most probably compound 4, exhibiting a glucuronidated 
hydroxamate moiety. 
The formation of monooxygenated products or metabolites arising from combined 
phase I and phase II biotransformation reactions could not be observed. Although 
these experiments were performed with rat liver microsomes rather than with human 
materials, the observations are in good agreement with the in silico predictions. Both 
the carboxylic acid metabolite 6 and the glucuronic acid metabolite 4 were predicted 
with SyGMa as two out of four metabolites. The transformation of the para-position of 
the terminal phenyl moiety, predicted by FAME 2 with a moderate likelihood, could not 




The envisaged carboxylic acid derivatives 13, 14, 15 and 16 were synthesized from 
ester 9 (Scheme 2), which can be accessed in enantiomerically pure form via a 
described procedure starting from 4-bromostyrene (8).38 In order to establish the 
lipophilic side chain of the compounds, a Sonogashira coupling of aryl bromide 9 with 
phenylacetylene was performed to yield diphenylacetylene derivative 10. 
Subsequently, the MOM protective group of ester 10 was cleaved under acidic 
conditions. When performing the reaction in ethanol, ethyl ester 12 was obtained. The 
use of methanol as solvent led to an additional transesterification, yielding methyl ester 
11. Whereas the saponification of ester 12 gave carboxylic acid 13, the aminolyses of 
esters 11 and 12 with ammonia and hydrazine yielded primary amide 14 and hydrazide 
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15, respectively.48-49 Finally, amide 16 was obtained by coupling carboxylic acid 13 
with 1,2-phenylenediamine in the presence of the carboxyl activating agent EDCI 
hydrochloride and N-hydroxysuccinimide.19, 50-51 
 
 
Scheme 2: Reagents and conditions: (a) phenylacetylene, Pd(PPh3)4, CuI, NEt3, Δ, 16 
h, 99 %; (b) HCl, MeOH or EtOH, rt, 16 h, 11 86 %, 12 84 %; (c) NaOH, THF, rt, 16 h, 
82 %; (d) aq. NH3, rt, 16 h, 75 %; (e) H2NNH2, EtOH, 37 %; (f) EDCI hydrochloride, N-
hydroxysuccinimide, 1,2-phenylenediamine, CH2Cl2, rt, 16 h, 29 %. 
 
In order to access thiol derivatives 20 and 22, ester 10 was reduced with DIBAL to 
yield primary alcohol 17 (Scheme 3).52 Subsequently, the alcohol was mesylated and 
the resulting methanesulfonic acid ester 18 was subjected to a nucleophilic substitution 
with thioacetic acid to obtain thioester 19.53-54 The removal of the MOM protective 
group of thioester 19 under acidic conditions also led to the cleavage of the 
compound’s thioester moiety, thus yielding thiol 20. In order to obtain thioester 22, at 
first, the MOM protective group of mesylate 21 was cleaved and thereafter a 





Scheme 3: Reagents and conditions: (a) DIBAL, CH2Cl2, rt, 30 min, 77 %; (b) mesyl 
chloride, NEt3, DMAP, CH2Cl2, rt, 2.5 h, 69 %; (c) thioacetic acid, NEt3, DMF, rt, 16 h, 
67 %; (d) HCl, MeOH, rt, 16 h, 53 %; (e) HCl, MeOH, rt, 16 h, 87 %; (f) thioacetic acid, 
NEt3, DMF, rt, 16 h, 72 %; (g) potassium phthalimide, DMF, 80 °C, 3 h, 84 %; (h) 
H2NCH3, EtOH, 70 °C, 16 h, 82 %; (i) HCl, EtOH, rt, 16 h, 41 %. 
 
The primary amine 24 (Scheme 3) represents an important intermediate in the 
synthesis of the envisaged carboxamide and sulfonamide derivatives. The compound 
could be accessed via a Gabriel synthesis. Thus, mesylate 18 was subjected to a 
nucleophilic substitution with potassium phthalimide, yielding N-alkylphthalimide 23, 
which was subsequently cleaved with methylamine to give primary amine 24.55 
Additionally, the MOM protective group of compound 24 was removed under acidic 
conditions yielding amine 25, which was also tested for antibacterial and LpxC 
inhibitory activity. 
Subsequently, primary amine 24 was coupled with pyrrole-2-carboxylic acid to give 
carboxamide 26 and reacted with mesyl chloride, triflyl chloride, and tosyl chloride to 
yield sulfonamides 28, 30, and 32, respectively (Scheme 4).56 These compounds were 
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Scheme 4: Reagents and conditions: (a) pyrrole-2-carboxylic acid, EDCI 
hydrochloride, HOBt, NEt3, CH2Cl2, rt, 16 h, 87 %; (b) H+, MeOH, rt, 82 %; (c) mesyl 
chloride, NEt3, CH2Cl2, rt, 16 h, 79 %; (d) HCl, MeOH, rt, 16 h, 85 %; (e) triflyl chloride, 
NEt3, CH2Cl2, rt, 16 h, 45 %; (f) HCl, MeOH, rt, 16 h, 63 %; (g) pTsCl, NEt3, CH2Cl2, rt, 
16 h, 85 %; (h) HCl, MeOH, rt, 16 h, 89 %.  
 
In order to obtain vicinal diols 38 and 39, secondary alcohol 34, which is another 
intermediate of the described synthesis of hydroxamic acid 3 and which is also 
accessible from 4-bromostyrene (8),38 was reacted with allyl bromide to give allyl ether 
35 (Scheme 5). The latter was subjected to a Sonogashira coupling with 
phenylacetylene, yielding diphenylacetylene derivative 36. After cleavage of the MOM 
protective group, Sharpless asymmetric dihydroxylations were performed with the 
resulting alcohol 37.57 When AD-mix-α was used, allyl ether 37 should be transformed 
into the (R)-configured vicinal diol 38, whereas the use of AD-mix-β should lead to the 
formation of the respective (S)-configured vicinal diol 39. However, the 
diastereoselectivities of the performed asymmetric dihydroxylations of allyl ether 37 
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were relatively low. Whereas the reported Sharpless asymmetric dihydroxylations of 
4-bromostyrene (8) had yielded the respective diols with high enantioselectivities (ee 
> 97 %),38 the diastereomeric excess of vicinal diols 38 (de = 60 %) and 39 (de = 20 
%) was rather poor. 
 
 
Scheme 5: Reagents and conditions: (a) allyl bromide, LiHMDS, NBu4I, THF, D, 16 h, 
64 %; (b) phenylacetylene, Pd(PPh3)4, CuI, NEt3, Δ, 16 h, 86 %; (c) HCl, MeOH, rt, 16 
h, 91 %; (d) AD-mix-α, tBuOH/H2O (1:1), 0 °C, 16 h, 38 93 %, de = 60 % or AD-mix-β, 
tBuOH/H2O (1:1), 0 °C, 16 h, 39 90 %, de = 20 %; (e) 1. 9-BBN, THF, rt, 17.5 h, 2. 
MeOH, aq. NaOH, aq. H2O2, -25 °C → 40 °C, 99 %; (f) phenylacetylene, Pd(PPh3)4, 
CuI, NEt3, Δ, 16 h, 78 %. 
 
Primary alcohol 41 was obtained from ether 35 via the hydroboration of its allyl 
substituent with 9-borabicyclononane (9-BBN) followed by an oxidative workup with 
NaOH/H2O2, yielding propanol derivative 40, and a subsequent Sonogashira coupling 
with phenylacetylene (Scheme 5).58-59  
Primary alcohols 17 and 41 were used as stating materials for the synthesis of 
hydroxypyridinone derivatives (Scheme 6). Thus, the compounds were transformed 
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into azides 44 and 45 via a tosylation and a subsequent substitution with sodium azide. 
The obtained azides 44 and 45 were subjected to a Staudinger reduction and the 
intermediately formed primary amines were reacted with benzyl-protected maltol (47) 
to yield pyridinone derivatives 48 and 49, respectively.60 Subsequently, both protective 
groups should be cleaved under acidic conditions. According to the literature, the 
benzyl protective group of the pyridinone derivatives should be removable under 
strongly acidic conditions.60 However, these conditions also led to the cleavage of the 
second benzyl ether moiety within the molecules and consequently to a degradation of 
the compounds. Thus, after the acid-catalyzed cleavage of the MOM protective groups 
of pyridinone derivatives 48 and 49, their benzyl groups were hydrogenolytically 
removed. However, under the latter reaction conditions, the triple bonds of the 
compounds were additionally hydrogenated, leading to the formation 1,2-
diphenylethane derivatives 50 and 51. 
 
 
Scheme 6: Reagents and conditions: (a) pTsCl, DMAP, NEt3, CH2Cl2, rt, 42 86 %, 43 
82 %; (b) NaN3, DMSO, D, 16 h, 44 92 %, 45 90 %; (c) BnBr, K2CO3, ACN, D, 16 h, 95 
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%; (d) 1. polymer-bound PPh3, THF, H2O, 2. 47, H2O, 140 °C, 7 d, 48 19 %, 49 14 %; 
(e) 1. HCl, MeOH, rt, 16 h, 2. H2, Pd/C, MeOH, rt, 16 h, 50 27 %, 51 26 %.  
 
For a better comparability, when elucidating the effect of the replacement of the 
hydroxamate group by a hydroxypyridinone moiety, two additional compounds were 
synthesized. On the one hand, the 1,2-diphenylethane-derived hydroxamic acid 53 
was prepared (Scheme 7). Staring from the described lactone 52,38 at first, the 
hydrogenation of its acetylene moiety was performed, followed by an aminolysis with 
hydroxylamine, yielding hydroxamic acid 53. 
 
 
Scheme 7: Reagents and conditions: (a) 1. H2, Pd/C, MeOH, rt, 16 h, 2. H2NOH·HCl, 
NaOMe, MeOH, rt, 16 h, 52 %. 
 
On the other hand, diphenylacetylene derivative 57 was synthesized (Scheme 8), 
which can be considered as a hydroxypyridinone-derived analogue of the described 
benzyloxyacetohydroxamic acid 58.38 The reaction of 2-(4-bromophenyl)ethylamine 
(54) with maltol derivative 47 yielded pyridinone derivative 55. After a Sonogashira 
coupling with phenylacetylene, the benzyl protective group was removed by heating 






Scheme 8: Reagents and conditions: (a) H2O, 140 °C, 10 d, 60 %; (b) phenylacetylene, 
Pd(PPh3)4, CuI, NEt3, ACN, Δ, 16 h, 67 %; (c) aq. HCl, MeOH, Δ, 4 h, 60 %.  
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2.4. Biological evaluation 
 
Table 1: Results of the biological evaluation of the synthesized inhibitors with various Zn2+-binding groups. n. d.: not determinable. *: not 
soluble in the assay buffer at a concentration of 200 µM. 
compound 
 
zone of inhibition [mm] MIC [µg/mL] enzyme assay 






D22 IC50 [µM] Ki [µM] 
338 
 
9.5 ± 0.4 20.5 ± 0.2 64 4 0.48 ± 0.23 0.066 ± 0.032 
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<6 <6 >64 >64 >200 - 
14 
 
<6 <6 >64 >64 >200 - 
15 
 
7.3 ± 1.2 9.8 ± 1.0 >64 >64 >200 - 
16 
 
<6 7.7 ± 1.5 >64 >64 >20* - 
20  <6 <6 >64 >64 >200 - 
22 
 
<6 <6 >64 >64 >200 - 
19 
 
25  12.0 ± 2.0 13.8 ± 1.4 >64 64 n.d. - 
27 
 
<6 <6 >64 >64 >20* - 
29 
 
<6 8.7 ± 0.6 >64 >64 >200 - 
31 
 
7.0 ± 1.0 7.7 ± 0.6 >64 >64 >20* - 
33 
 
<6 <6 >64 >64 >200 - 
38 
(de = 60 %)  7.8 ± 1.6 8.7 ± 1.5 >64 >64 
>200 - 
39 
(de = 20 %)  8.0 ± 1.7 8.5 ± 0.9 >64 >64 >200 - 
compound 
 










D22 IC50 [µM] Ki [µM] 
50 
 
<6 <6 >64 >64 >200 - 
51 
 
<6 <6 >64 >64 >200 - 
53 
 
<6 <6 >64 >64 >200 - 
compound 
 












D22 IC50 [µM] Ki [µM] 
57 
 
<6 <6 >64 >64 >200 - 
5838 
 




In order to evaluate the antibacterial activities of the synthesized compounds, disc 
diffusion tests with E. coli BL21 (DE3) and the defective E. coli strain D22,61 which is 
more sensitive towards LpxC inhibition, were performed and the MIC (minimal 
inhibitory concentration) values of the potential LpxC inhibitors were determined (Table 
1). Additionally, a fluorescence-based LpxC enzyme assay was performed to test the 
inhibitory activity of the synthesized compounds against the isolated enzyme.62 In the 
LpxC enzyme assay, purified E. coli LpxCC63A was employed, as the C63A mutation 
lowers the undesired influence of Zn2+-concentration on enzymatic activity.5, 63 The 
inhibition of the deacetylation of the enzyme’s natural substrate 1 (Scheme 1) caused 
by a certain concentration of the putative inhibitors (ranging from 0.2 nM to 200 µM) 
was determined by transforming the resulting deacetylated primary amine 2 into a 
fluorescent isoindole with phthalaldehyde and 2-mercaptoethanol.  
As under the conditions of the enzyme assay primary amine 25 gave a fluorescent 
product itself, an IC50 value could not be determined for this compounds. For all the 
other phenylethylene glycol derivatives the results of the enzyme assay clearly showed 
that the replacement of the hydroxamate moiety of compound 3 by any other of the 
investigated functional groups is detrimental for the inhibitory activity toward LpxC. 
None of the assayed compounds was able to inhibit the enzymatic activity of LpxC by 
more than half at the highest concentrations tested. These data are in general 
agreement with the observed antibacterial activities. 
Whereas carboxylic acid 13, amide 14, thiol 20 and thioester 22 did not show any 
antibacterial activity, neither in the disc diffusion nor in the MIC assays, hydrazide 15 
was found to be able to inhibit the growth of both E. coli strains in the performed disc 
diffusion assays. However, the diameters of the observed halos of inhibition caused by 
this compound, which should be able to chelate the catalytic Zn2+-ion of LpxC in a 
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similar fashion as hydroxamic acid 3, are considerably smaller compared to the ones 
caused by the latter compound. Also 1,2-phenylenediamine derivative 16 as well as 
vicinal diols 38 and 39 caused observable halos of inhibition, particularly against the 
sensitive E. coli D22 strain. Whereas pyrrole-2-carboxamide 27 was found to exhibit 
no antibacterial activity, among the investigated sulfonamides 29, 31, and 33, 
noticeable halos of inhibition were found for mesylamide 29 and triflylamide 31. In 
contrast, no inhibition of bacterial growth was observed for sulfonamide 33.  
Surprisingly, primary amine 25 caused quite large halos of inhibition, which however 
did not translate into low MIC values. Due to its primary amino group, the inhibitory 
activity of compound 25 could not be determined using the fluorescence-based LpxC 
enzyme assay. Thus, it still needs to be elucidated, whether the observed antibacterial 
activity in the disc diffusion assays is due to inhibitory activity of the compound toward 
LpxC or due to unspecific cytotoxicity, the latter being indicated by halos of inhibition 
of approximately the same size when being assayed against E. coli BL21 and the 
sensitive E. coli strain D22.  
The hydroxypyridinone derivatives 50 and 51 also exhibit no antibacterial activity. 
However, their inactivity in the performed assays could be attributed to their flexible 
side chain, as the hydrogenation of the triple bond of the diphenylacetylene moiety also 
led to the complete inactivity of hydroxamic acid 53. This finding is in agreement with 
previous observations that in case of the benzyloxyacetohydroxamic acids a long, 
linear, and rigid lipophilic side chain is required for potent LpxC inhibitory activity.38, 64  
Additional evidence that the replacement of the hydroxamate group by a 
hydroxypyridinone is unfavorable for the biological activity of the compounds is given 
by hydroxypyridinone derivative 57, which, in contrast to benzyloxyacetohydroxamic 





In divergent syntheses, phenylethylene glycol derivatives exhibiting various Zn2+-
binding groups, like e.g. carboxylate, hydrazide, amide, sulfonamide, and thiol 
moieties, were obtained. The biological evaluation of the synthesized compounds 
revealed that the replacement of the hydroxamate moiety of compound 3 by other Zn2+-
binding groups is detrimental for the LpxC inhibitory and antibacterial activity of the 
phenylethylene glycol derivatives. For this reason, the metabolic stability of none of the 
newly synthesized compounds exhibiting an alternative Zn2+-binding group was 
investigated. Thus, hydroxamic acid 3, whose hydroxamate moiety was shown by in 
silico predictions as well as by in vitro experiments to be the major metabolically labile 
position of the compound, still represents the most potent LpxC inhibitor of the 
presented phenylethylene glycol derivatives. In consequence, further efforts need to 
be undertaken to find suitable Zn2+-binding groups that can replace the hydroxamate 





4. Experimental Section 
4.1. Chemistry, general 
Unless otherwise mentioned, THF was dried with sodium/benzophenone and was 
freshly distilled before use. Thin layer chromatography (TLC): Silica gel 60 F254 plates 
(Merck). Reversed phase thin layer chromatography (RP-TLC): Silica gel 60 RP-18 
F254S plates (Merck). Flash chromatography (FC): Silica gel 60, 40 – 64 µm (Macherey-
Nagel); brackets include: diameter of the column, fraction size, eluent. Automatic flash 
column chromatography: IsoleraTM One (Biotage®); brackets include: eluent, cartridge-
type. Melting point: Melting point apparatus SMP 3 (Stuart Scientific), uncorrected. 
Optical rotation α [deg] was determined with a Polarimeter 341 (Perkin Elmer); path 
length 1 dm, wavelength 589 nm (sodium D line); the unit of the specific rotation ["]$%& 
[deg . mL . dm-1 . g-1] is omitted; the concentration of the sample c [mg . mL-1] and the 
solvent used are given in brackets. 1H NMR (400 MHz), 13C NMR (100 MHz): Agilent 
DD2 400 MHz spectrometer; δ in ppm related to tetramethylsilane. IR: IR Prestige-21 
(Shimadzu). APCI/LC-MS: MicrOTOF-QII (Bruker). HPLC methods for the 
determination of product purity: Method 1: Merck Hitachi Equipment; UV detector: L-
7400; autosampler: L-7200; pump: L-7100; degasser: L-7614; column: LiChrospher® 
60 RP-select B (5 μm); LiChroCART® 250-4 mm cartridge; flow rate: 1.00 mL/min; 
injection volume: 5.0 µL; detection at λ = 210 nm for 30 min; solvents: A: water with 
0.05 % (V/V) trifluoroacetic acid; B: acetonitrile with 0.05 % (V/V) trifluoroacetic acid: 
gradient elution: (A %): 0 – 4 min: 90 % , 4 – 29 min: gradient from 90 % to 0 %, 29 – 
31 min: 0 %, 31 – 31.5 min: gradient from 0 % to 90 %, 31.5 – 40 min: 90 %. Method 
2: Merck Hitachi Equipment; UV detector: L-7400; pump: L-6200A; column: 
phenomenex Gemini® 5 µm C6-Phenyl 110 Å; LC Column 250 x 4.6 mm; flow rate: 
1.00 mL/min; injection volume: 5.0 µL; detection at λ = 254 nm for 20 min; solvents: A: 
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acetonitrile : 10 mM ammonium formate = 10 : 90 with 0.1 % formic acid; B: acetonitrile 
: 10 mM ammonium formate = 90 : 10 with 0.1 % formic acid; gradient elution: (A %): 
0 – 5 min: 100 % , 5 – 15 min: gradient from 100 % to 0 %, 15 – 20 min: 0 %, 20 – 22 
min: gradient from 0 % to 100 %, 22 – 30 min: 100 %. 
 




Under N2 atmosphere, copper(I) iodide (50 mg, 0.26 mmol), 
tetrakis(triphenylphosphine)palladium(0) (200 mg, 0.18 mmol) and phenylacetylene 
(0.27 mL, 250 mg, 2.5 mmol) were added to a solution of 9 (610 mg, 1.8 mmol) in 
triethylamine (40 mL). The mixture was heated to reflux and additional phenylacetylene 
(0.27 mL, 250 mg, 2.5 mmol) was added. After stirring the mixture under reflux 
conditions for 16 h, the solvent was evaporated and the residue was purified by flash 
column chromatography (Ø = 3 cm, h = 15 cm, cyclohexane/ethyl acetate = 8:2, 
V = 20 mL) to give 10 as yellowish oil (650 mg, 1.8 mmol, 99 % yield). Rf = 0.68 
(cyclohexane/ethyl acetate = 2:1); specific rotation: [α]$%& = +91.4 (3.5; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 1.26 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 3.29 (s, 3H, 
OCH2OCH3), 3.71 (dd, J = 10.8/4.3 Hz, 1H, OCHCH2O), 3.84 (dd, J = 10.8/7.2 Hz, 1H, 
OCHCH2O), 3.99 (d, J = 16.3 Hz, 1H, OCH2CO2Et), 4.11 (d, J = 16.3 Hz, 1H, 
OCH2CO2Et), 4.15-4.23 (m, 2H, CO2CH2CH3), 4.64 (d, J = 6.6 Hz, 1H, OCH2OCH3), 
4.67 (d, J = 6.6 Hz, 1H, OCH2OCH3), 4.69 (dd, J = 7.2/4.3 Hz, 1H, OCHCH2O), 7.31-
7.39 (m, 5H, Harom.), 7.49-7.56 (m, 4H, Harom.); 13C NMR (CDCl3): δ [ppm] = 14.3 (1C, 
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CO2CH2CH3), 55.5 (1C, OCH2OCH3), 61.0 (1C, CO2CH2CH3), 66.5 (1C, OCH2CO2Et), 
71.3 (1C, OCHCH2O), 81.4 (1C, OCHCH2O), 89.1 (1C, C≡C), 89.9 (1C, C≡C), 96.7 
(1C, OCH2OCH3), 123.3 (1C, Carom.), 123.5 (1C, Carom.), 127.4 (2C, Carom.), 128.49 (1C, 
Carom.), 128.50 (2C, Carom.), 131.8 (2C, Carom.), 131.9 (2C, Carom.), 138.5 (1C, Carom.), 
170.3 (1C, CO2Et); IR (neat): ṽ [cm-1] = 2928, 1751, 1508, 1443, 1381, 1277, 1200, 
1111, 1034, 918, 837, 756, 691; HRMS (m/z): [M+H]+ calcd for C22H25O5: 369.1697, 
found: 369.1664; HPLC (method 1): tR = 22.0 min, purity 97.5 %. 
 
4.2.2. Methyl (S)-2-{2-hydroxy-1-[4-(phenylethynyl)phenyl]ethoxy}acetate (11) 
10 (100 mg, 0.28 mmol) was dissolved in HCl-saturated methanol (5 mL). The reaction 
mixture was stirred at ambient temperature for 16 h. After addition of a saturated 
aqueous solution of sodium bicarbonate and water, the mixture was extracted with 
ethyl acetate (3×). The combined organic layers were dried over sodium sulfate, 
filtered, and the solvent was removed in vacuo. The residue was purified by flash 
column chromatography (Ø = 2 cm, h = 17 cm, cyclohexane/ethyl acetate = 8:2 → 2:1, 
V = 10 mL) to give 11 as colorless oil (73 mg, 0.24 mmol, 86 % yield). Rf = 0.21 
(cyclohexane/ethyl acetate = 2:1); specific rotation: [α]$%& = +175.9 (3.4; CH2Cl2); 1H 
NMR: (CD3OD): δ [ppm] = 3.63 (dd, J = 11.8/4.0 Hz, 1H, OCHCH2OH), 3.72 (s, 3H, 
OCH2CO2CH3), 3.74 (dd, J = 11.8/7.4 Hz, 1H, OCHCH2OH), 4.04 (d, J = 16.3 Hz, 1H, 
OCH2CO2CH3), 4.11 (d, J = 16.3 Hz, 1H, OCH2CO2CH3), 4.54 (dd, J = 7.4/4.0 Hz, 1H, 
OCHCH2OH), 7.34-7.40 (m, 5H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 
5"-Hphenyl, 4"-Hphenyl), 7.47-7.55 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 
2"-Hphenyl, 6"-Hphenyl); 13C NMR (CD3OD): δ [ppm] = 52.4 (1C, CO2CH3), 67.2 (1C, 
OCH2CO2CH3), 67.4 (1C, OCHCH2OH), 84.7 (1C, OCHCH2OH), 89.8 (1C, C≡C), 90.4 
(1C, C≡C), 124.46 (1C, Carom.), 124.48 (1C, Carom.), 128.4 (2C, C-2'4-(phenylethynyl)phenyl, C-
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6'4-(phenylethynyl)phenyl), 129.5 (1C, C-4"phenyl), 129.6 (2C, C-3"phenyl, C-5"phenyl), 132.5 (2C, 
Carom.), 132.7 (2C, Carom.), 140.0 (1C, C-1'4-(phenylethynyl)phenyl), 172.8 (1C, CO2CH3); IR 
(neat): ṽ [cm-1] = 3456, 2951, 1740, 1508, 1439, 1408, 1377, 1215, 1126, 1053, 833, 
756, 691; LCMS (m/z): [M+Na]+ calcd for C19H18NaO4: 333.1097, found: 333.1097; 
HPLC (method 1): tR = 21.1 min, purity 95.7 %. 
 
4.2.3. Ethyl (S)-2-{2-hydroxy-1-[4-(phenylethynyl)phenyl]ethoxy}acetate (12) 
10 (120 mg, 0.31 mmol) was dissolved in HCl-saturated ethanol (4 mL). The reaction 
was stirred at ambient temperature for 16 h. After addition of a saturated aqueous 
solution of sodium bicarbonate and water the mixture was extracted with ethyl acetate 
(3×). The combined organic layers were dried over sodium sulfate, filtered, and the 
solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 2 cm, h = 15 cm, cyclohexane/ethyl acetate = 8:2 → 2:1, 
V = 10 mL) to give 12 as yellowish oil (84 mg, 0.26 mmol, 84 % yield). Rf = 0.14 
(cyclohexane/ethyl acetate = 3:1); specific rotation: [α]$%& = +156.2 (2.6; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 1.29 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 3.65 (dd, J = 11.8/3.2 
Hz, 1H, OCHCH2OH), 3.76 (dd, J = 11.8/8.8 Hz, 1H, OCHCH2OH), 3.94 (d, J = 16.8 
Hz, 1H, OCH2CO2Et), 4.20 (d, J = 16.8 Hz, 1H, OCH2CO2Et), 4.21-4.28 (m, 2H, 
CO2CH2CH3), 4.52 (dd, J = 8.8/3.2 Hz, 1H, OCHCH2OH), 7.29-7.39 (m, 5H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.50-7.56 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR (CDCl3): 
δ [ppm] = 14.3 (1C, CO2CH2CH3), 61.5 (1C, CO2CH2CH3), 66.5 (1C, OCH2CO2Et), 
67.3 (1C, OCHCH2OH), 84.6 (1C, OCHCH2OH), 89.0 (1C, C≡C), 90.0 (1C, C≡C), 
123.2 (1C, C-1"phenyl), 123.6 (1C, C-4'4-(phenylethynyl)phenyl), 126.9 (2C, C-2'4-
(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.51 (2C, C-3"phenyl, C-5"phenyl), 128.53 (1C, 
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C-4"phenyl), 131.8 (2C, C-2"phenyl, C-6"phenyl), 132.0 (2C, C-3'4-(phenylethynyl)phenyl, C-
5'4-(phenylethynyl)phenyl), 137.9 (1C, C-1'4-(phenylethynyl)phenyl), 171.3 (1C, CO2Et); IR (neat): ṽ 
[cm-1] = 3437, 2970, 1736, 1508, 1443, 1381, 1215, 1126, 949, 837, 756, 691; LCMS 
(m/z): [M+H]+ calcd for C20H21O4: 325.1434, found: 325.1469; HPLC (method 1): tR = 
22.1 min, purity 97.7 %. 
 
4.2.4. (S)-2-{2-Hydroxy-1-[4-(phenylethynly)phenyl]ethoxy}acetic acid (13) 
12 (310 mg, 0.95 mmol) was dissolved in THF (3 mL) and a 1 M aqueous solution of 
NaOH (10 mL) was added. The reaction was stirred at ambient temperature for 16 h. 
Then the mixture was acidified with a 1 M aqueous solution of HCl and extracted with 
ethyl acetate (3×). The combined organic layers were dried over sodium sulfate, 
filtered, and the solvent was removed in vacuo to give 13 as a colorless solid (230 mg, 
0.78 mmol, 82 % yield). Rf = 0.41 (dichloromethane/methanol = 9:1); melting point: 
122 °C; specific rotation: [α]$%& = +87.3 (2.2; CH2Cl2); 1H NMR (CD3OD): δ [ppm] = 
3.63 (dd, J = 11.8/3.9 Hz, 1H, OCHCH2OH), 3.74 (dd, J = 11.8/7.5 Hz, 1H, 
OCHCH2OH), 3.99 (d, J = 16.5 Hz, 1H, OCH2CO2H), 4.08 (d, J = 16.5 Hz, 1H, 
OCH2CO2H), 4.54 (dd, J = 7.5/3.9 Hz, 1H, OCHCH2OH), 7.30-7.41 (m, 5H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 
7.45-7.59 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl,); 13C 
NMR (CD3OD): δ [ppm] =67.1 (1C, OCH2CO2H), 67.4 (1C, OCHCH2OH), 
84.7 (1C, OCHCH2OH), 89.8 (1C, C≡C), 90.4 (1C, C≡C), 124.47 (1C, Carom.), 124.49 
(1C, Carom.), 128.4 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 129.5 (1C, C-
4"phenyl), 129.6 (2C, C-3"phenyl, C-5"phenyl), 132.5 (2C, Carom.), 132.7 (2C, Carom.), 
140.0 (1C, C-1'4-(phenylethynyl)phenyl), 174.2 (1C, OCH2CO2H); IR (neat): ṽ [cm-1] = 2978, 
2889, 1739, 1597, 1508, 1385, 1242, 1126, 1072, 1053, 953, 833, 752, 687; LCMS 
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(m/z): [M+NH4]+ calcd for C18H20NO4: 314.1387, found: 314.1416; HPLC (method 2): 
tR = 17.0 min, purity 98.0 %. 
 
4.2.5. (S)-2-{2-Hydroxy-1-[4-(phenylethynyl)phenyl]ethoxy}acetamide (14) 
An emulsion of 11 (55 mg, 0.18 mmol) in ammonia solution (ca. 25 % NH3, 4 mL) was 
stirred at ambient temperature overnight. The formed precipitate was filtered off, 
washed with water (3×) and dried in a desiccator for 7 d to give 14 as colorless solid 
(40 mg, 0.14 mmol, 75 % yield). Rf = 0.34 (dichloromethane/methanol = 9:1); melting 
point: 139 °C; specific rotation: [α]$%& = +127.1 (2.9; CH3OH); 1H NMR: (CD3OD): 
δ [ppm] = 3.64 (dd, J = 11.9/3.5 Hz, 1H, OCHCH2OH), 3.71 (dd, J = 11.9/8.0 Hz, 1H, 
OCHCH2OH), 3.81 (d, J = 15.7 Hz, 1H, OCH2CONH2), 3.93 (d, J = 15.7 Hz, 1H, 
OCH2CONH2), 4.51 (dd, J = 8.0/3.5 Hz, 1H, OCHCH2OH), 7.33-7.41 (m, 5H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.48-7.56 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR: (CD3OD): 
δ [ppm] = 67.4 (1C, OCHCH2OH), 69.0 (1C, OCH2CONH2), 85.3 (1C, OCHCH2OH), 
89.7 (1C, C≡C), 90.5 (1C, C≡C), 124.5 (1C, Carom.), 124.6 (1C, Carom.), 128.2 (2C, C-
2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 129.5 (1C, C-4"phenyl), 129.6 (2C, C-3"phenyl, 
C-5"phenyl), 132.5 (2C, C-2"phenyl, C-6"phenyl), 132.8 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-
(phenylethynyl)phenyl), 139.7 (1C, C-1'4-(phenylethynyl)phenyl), 175.6 (1C, CONH2); IR (neat): ṽ [cm-
1] = 3348, 3194, 2978, 2913, 1686, 1655, 1597, 1504, 1412, 1331, 1238, 1107, 1076, 
1049, 833, 756, 691; LCMS (m/z): [M+H]+ calcd for C18H18NO3: 296.1281, found: 
296.1289; HPLC (method 2): tR = 16.2 min, purity 97.2 %. 
 
4.2.6. (S)-2-{2-Hydroxy-1-[4-(phenylethynyl)phenyl]ethoxy}acetohydrazide (15) 
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After heating a solution of hydrazine monohydrate (98%, 0.20 mL, 210 mg, 4.1 mmol) 
in ethanol (6 mL) to reflux for 5 min, a solution of 12 (170 mg, 0.54 mmol) in ethanol 
(6 mL) was added and the mixture was heated to reflux for 75 min and then stirred at 
ambient temperature overnight. After removing the solvent in vacuo, the residue was 
purified by flash column chromatography (1. Ø = 2 cm, h = 15 cm, 
ethyl acetate/methanol = 100:0 → 10:1, V = 10 mL; 2. Ø = 2 cm, h = 15 cm, 
dichloromethane/ methanol = 98:2 → 95:5, V = 10 mL) to give 15 as colorless solid 
(61 mg, 0.20 mmol, 37 % yield). Rf = 0.23 (ethyl acetate/methanol = 10:1); melting 
point: 104 °C; specific rotation: [α]$%& = +106.5 (3.0; CH3OH); 1H NMR (DMSO-d6): 
δ [ppm] = 3.41-3.64 (m, 2H, OCHCH2OH), 3.78 (d, J = 14.8 Hz, 1H, OCH2CONH), 3.85 
(d, J = 14.8 Hz, 1H, OCH2CONH), 4.20-4.55 (m, 2H, CONHNH2), 4.45 (dd, J = 
7.3/3.4 Hz, 1H, OCHCH2OH), 5.21-5.34 (m, 1H, OCHCH2OH), 7.32-7.49 (m, 5H, 2'-
H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.49-7.63 (m, 
4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl), 9.19 (s, 1H, 
CONHNH2); 13C NMR (DMSO-d6): δ [ppm] = 65.5 (1C, OCHCH2OH), 67.7 (1C, 
OCH2CONH), 83.2 (1C, OCHCH2OH), 89.2 (1C, C≡C), 89.3 (1C, C≡C), 121.7 (1C, C-
4'4-(phenylethynyl)phenyl), 122.2 (1C, C-1"phenyl), 127.3 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-
(phenylethynyl)phenyl), 128.76 (2C, C-3"phenyl, C-5"phenyl), 128.80 (1C, C-4"phenyl), 131.3 (2C, 
Carom.), 131.4 (2C, Carom.), 139.5 (1C, C-1'4-(phenylethynyl)phenyl), 168.0 (1C, CONHNH2); IR 
(neat): ṽ [cm-1] = 3294, 2909, 1651, 1632, 1535, 1508, 1443, 1335, 1119, 1049, 833, 
756, 691; LCMS (m/z): [M+H]+ calcd for C18H19N2O3: 311.1390, found: 311.1384; 






Under N2 atmosphere, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) 
hydrochloride (65 mg, 0.34 mmol), N-hydroxysuccinimide (39 mg, 0.34 mmol) and 1,2-
phenylenediamine (37 mg, 0.34 mmol) were added to a solution of 13 (100 mg, 
0.34 mmol) in dry dichloromethane (15 mL). The reaction mixture was stirred under N2 
atmosphere (balloon) at ambient temperature for 16 h. Then water was added and the 
mixture was extracted with dichloromethane (3×). The combined organic layers were 
dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The residue 
was purified by flash column chromatography (Ø = 2 cm, h = 20 cm, 
dichloromethane/methanol = 100:0 → 9:1, V = 20 mL) to give 16 as yellowish solid (38 
mg, 0.10 mmol, 29 % yield). Rf = 0.23 (cyclohexane/ethyl acetate = 1:2); melting point: 
134 °C; specific rotation: [α]$%& = +115.2 (2.5; CH2Cl2); 1H NMR (CD3OD): δ [ppm] = 
3.70 (dd, J = 11.9/3.2 Hz, 1H, OCHCH2OH), 3.76 (dd, J = 11.9/8.5 Hz, 1H, 
OCHCH2OH), 4.00 (d, J = 15.8 Hz, 1H, OCH2CONH), 4.17 (d, J = 15.8 Hz, 1H, 
OCH2CONH), 4.65 (dd, J = 8.5/3.2 Hz, 1H, OCHCH2OH), 6.74 (td, J = 7.6/1.4 Hz, 1H, 
5'''-H2-aminophenyl), 6.88 (dd, J = 8.0/1.4 Hz, 1H, 3'''-H2-aminophenyl), 7.05 (ddd, 
J = 8.0/7.4/1.5 Hz, 1H, 4'''-H2-aminophenyl), 7.24 (dd, J = 7.8/1.5 Hz, 1H, 6'''-H2-aminophenyl), 
7.34-7.40 (m, 3H, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.42-7.46 (m, 2H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl), 7.49-7.54 (m, 2H, 2"-Hphenyl, 6"-Hphenyl), 7.54-
7.58 (m, 2H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl); 13C NMR (CD3OD): 
δ [ppm] = 67.3 (1C, OCHCH2OH), 69.6 (1C, OCH2CONH), 85.7 (1C, OCHCH2OH), 
89.7 (1C, C≡C), 90.6 (1C, C≡C), 118.5 (1C, 3'''-C2-aminophenyl), 119.5 (1C, 5'''-C2-
aminophenyl), 124.2 (1C, 1'''-C2-aminophenyl), 124.5 (1C, C-1"phenyl), 124.7 (1C, C-4'4-
(phenylethynyl)phenyl), 127.1 (1C, 6'''-C2-aminophenyl), 128.3 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-
(phenylethynyl)phenyl), 128.5 (1C, 4'''-C2-aminophenyl), 129.5 (1C, C-4"phenyl), 129.6 (2C, 
C-3"phenyl, C-5"phenyl), 132.5 (2C, C-2"phenyl, C-6"phenyl), 132.8 (2C, C-3'4-(phenylethynyl)phenyl, 
C-5'4-(phenylethynyl)phenyl), 139.6 (1C, C-1'4-(phenylethynyl)phenyl), 143.2 (2'''-C2-aminophenyl), 171.4 
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(1C, CONH); IR (neat): ṽ [cm-1] = 3472, 3383, 3310, 2924, 2866, 1663, 1616, 1531, 
1504, 1458, 1335, 1312, 1269, 1111, 1057, 833, 748, 691; LCMS (m/z): [M+H]+ calcd 





Under N2 atmosphere, a 1.2 M solution of diisobutylaluminium hydride in toluene 
(14 mL, 17 mmol) was added to a solution of 10 (2.8 g, 7.6 mmol) in dry 
dichloromethane (100 mL). The mixture was stirred at ambient temperature. After 30 
min the reaction was terminated by adding a saturated aqueous solution of Rochelle 
salt (50 mL). Then diethyl ether (100 mL) was added and the mixture was vigorously 
stirred until two clear layers appeared. The aqueous layer was extracted with ethyl 
acetate (3×). The combined organic layers were dried over sodium sulfate, filtered, and 
the solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 6 cm, h = 15 cm, cyclohexane/ethyl acetate = 8:2 → 100% ethyl 
acetate, V = 50 mL) to give 17 as colorless oil (1.9 g, 5.9 mmol, 77 % yield). Rf = 0.41 
(cyclohexane/ethyl acetate = 1:1); specific rotation: [α]$%& = +56.8 (3.1; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 3.34 (s, 3H, OCH2OCH3), 3.51 (ddd, J = 10.7/6.0/3.8 Hz, 1H, 
HOCH2CH2O), 3.63 (ddd, J = 10.7/5.4/3.3 Hz, 1H, HOCH2CH2O), 3.66 (dd, J = 10.9/3.7 
Hz, 1H, OCHCH2O), 3.71-3.78 (m, 3H, HOCH2CH2O, OCHCH2O (1H)), 4.58 (dd, J = 
8.0/3.7 Hz, 1H, OCHCH2O), 4.67 (s, 2H, OCH2OCH3), 7.31-7.37 (m, 5H, Harom.), 7.51-
7.55 (m, 4H, Harom.); 13C NMR (CDCl3): δ [ppm] = 55.5 (1C, OCH2OCH3), 62.0 (1C, 
HOCH2CH2O), 70.9 (1C, HOCH2CH2O), 72.1 (1C, OCHCH2O), 81.8 (1C, OCHCH2O), 
89.1 (1C, C≡C), 89.8 (1C, C≡C), 96.9 (1C, OCH2OCH3), 123.2 (1C, Carom.), 123.3 (1C, 
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Carom.), 127.0 (2C, Carom.), 128.47 (1C, Carom.), 128.49 (2C, Carom.), 131.8 (2C, Carom.), 
131.9 (2C, Carom.), 139.3 (1C, Carom.); IR (neat): ṽ [cm-1] = 3429, 2927, 2882, 1597, 
1508, 1443, 1408, 1343, 1211, 1150, 1107, 1030, 918, 833, 756, 691; HRMS (m/z): 
[M+H]+ calcd for C20H23O4: 327.1591, found: 327.1563; HPLC (method 1): tR = 




Under N2 atmosphere, triethylamine (1.6 mL, 1.2 g, 12 mmol), DMAP (140 mg, 
1.2 mmol) and methanesulfonyl chloride (0.9 mL, 1.3 g, 12 mmol) were added to a 
solution of 17 (1.9 g, 5.9 mmol) in dry dichloromethane (100 mL). The reaction was 
stirred for 2.5 h at ambient temperature. Then water and a saturated aqueous solution 
of sodium bicarbonate were added and the mixture was extracted with 
dichloromethane (3×). The combined organic layers were dried over sodium sulfate, 
filtered, and the solvent was evaporated in vacuo. The residue was purified by flash 
column chromatography (Ø = 6 cm, h = 15 cm, cyclohexane/ethyl acetate = 8:2→ 2:1, 
V = 50 mL) to give 18 as colorless solid (1.7 g, 4.1 mmol, 69 % yield). Rf = 0.22 
(cyclohexane/ethyl acetate = 2:1); melting point: 59 °C; specific rotation: [α]$%& = +27.4 
(2.4; CH2Cl2); 1H NMR (CD2Cl2): δ [ppm] = 3.05 (s, 3H, OSO2CH3), 3.28 (s, 3H, 
OCH2OCH3), 3.63 (dd, J = 10.9/4.1 Hz, 1H, OCHCH2O), 3.65-3.71 (m, 2H, 
OCH2CH2OS) 3.74 (dd, J = 10.9/7.4 Hz, 1H, OCHCH2O), 4.32-4.37 (m, 2H, 
OCH2CH2OS), 4.56 (dd, J = 7.4/4.1 Hz, 1H, OCHCH2O), 4.60 (d, J = 6.5 Hz, 1H, 
OCH2OCH3), 4.62 (d, J = 6.5 Hz, 1H, OCH2OCH3), 7.32-7.40 (m, 5H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.50-7.57 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR (CD2Cl2): 
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δ [ppm] = 38.1 (1C, OSO2CH3), 55.6 (1C, OCH2OCH3), 67.7 (1C, OCH2CH2OS), 70.2 
(1C, OCH2CH2OS), 72.0 (1C, OCHCH2O), 82.3 (1C, OCHCH2O), 89.5 (1C, C≡C), 90.1 
(1C, C≡C), 97.2 (1C, OCH2OCH3), 123.6 (1C, Carom.), 123.7 (1C, Carom.), 127.7 (2C, C-
2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.98 (1C, C-4"phenyl), 128.99 (2C, C-3"phenyl, 
C-5"phenyl), 132.1 (2C, Carom.), 132.2 (2C, Carom.), 139.6 (1C, C-1'4-(phenylethynyl)phenyl); IR 
(neat): ṽ [cm-1] = 2932, 1508, 1443, 1350, 1173, 1107, 1034, 1018, 968, 914, 833, 799, 
756, 691; LCMS (m/z): [M+H]+ calcd for C21H25O6S: 405.1366, found: 405.1365; HPLC 




Triethylamine (40 µL, 26 mg, 0.26 mmol) was added to a solution of 18 (97 mg, 
0.24 mmol) in DMF (10 mL). Then thioacetic acid (20 µL, 19 mg, 0.25 mmol) was 
added dropwise to the mixture. The reaction was stirred at ambient temperature for 
16 h. After the addition of water, the mixture was extracted with ethyl acetate (3×). The 
combined organic layers were dried over sodium sulfate, filtered, and the solvent was 
removed in vacuo. The residue was purified by flash column chromatography 
(Ø = 2 cm, h = 15 cm, cyclohexane/ ethyl acetate = 10:1 → 8:2, V = 10 mL) to give 19 
as reddish oil (61 mg, 0.16 mmol, 67 % yield). Rf = 0.38 (cyclohexane/ethyl 
acetate = 8:2); specific rotation: [α]$%& = +81.7 (2.6; CH2Cl2); 1H NMR (CD2Cl2): 
δ [ppm] = 2.31 (s, 3H, SCOCH3), 3.01-3.14 (m, 2H, OCH2CH2S), 3.27 (s, 3H, 
OCH2OCH3), 3.44-3.57 (m, 2H, OCH2CH2S), 3.60 (dd, J = 10.8/4.3 Hz, 1H, 
OCHCH2O), 3.71 (dd, J = 10.8/7.2 Hz, 1H, OCHCH2O), 4.51 (dd, J = 7.2/4.3 Hz, 1H, 
OCHCH2O), 4.59 (d, J = 6.5 Hz, 1H, OCH2OCH3), 4.62 (d, J = 6.5 Hz, 1H, 
OCH2OCH3), 7.32-7.40 (m, 5H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 
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5"-Hphenyl, 4"-Hphenyl), 7.50-7.57 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-
Hphenyl, 6"-Hphenyl); 13C NMR (CD2Cl2): δ [ppm] = 29.6 (1C, OCH2CH2S), 30.9 (1C, 
SCOCH3), 55.6 (1C, OCH2OCH3), 68.5 (1C, OCH2CH2S), 71.9 (1C, OCHCH2O), 81.9 
(1C, OCHCH2O), 89.6 (1C, C≡C), 89.9 (1C, C≡C), 97.2 (1C, OCH2OCH3), 123.3 (1C, 
Carom.), 123.7 (1C, Carom.), 127.7 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.9 
(1C, C-4"phenyl), 129.0 (2C, C-3"phenyl, C-5"phenyl), 132.1 (4C, C-3'4-(phenylethynyl)phenyl, C-5'4-
(phenylethynyl)phenyl, C-2"phenyl, C-6"phenyl), 140.3 (1C, C-1'4-(phenylethynyl)phenyl), 195.7 (1C, 
SCOCH3); IR (neat): ṽ [cm-1] = 2928, 1690, 1508, 1443, 1354, 1103, 1034, 953, 918, 
837, 756, 691, 625; LCMS (m/z): [M+H]+ calcd for C22H25O4S: 385.1468, found: 
385.1456; HPLC (method 1): tR = 24.7 min, purity 98.1 %. 
 
4.2.11. (S)-2-(2-Mercaptoethoxy)-2-[4-(phenylethynyl)phenyl]ethan-1-ol (20) 
19 (58 mg, 0.15 mmol) was dissolved in HCl-saturated methanol (7.5 mL). The 
reaction was stirred at ambient temperature for 16 h. After addition of a saturated 
aqueous solution of sodium bicarbonate and water the mixture was extracted with ethyl 
acetate (3×). The combined organic layers were dried over sodium sulfate, filtered, and 
the solvent was removed in vacuo. The residue was purified by automatic flash column 
chromatography (100% H20→ 100% ACN, Biotage® SNAP KP-C18-HS 12 g, 
V = 20 mL) to give 20 as colorless oil (25 mg, 0.08 mmol, 53 % yield). Rf = 0.21 
(cyclohexane/ethyl acetate = 3:1); specific rotation: [α]$%& = +99.0 (1.7; CH3OH); 1H 
NMR (CD3OD): δ [ppm] = 2.64-2.72 (m, 2H, OCH2CH2SH), 3.53 (t, J = 6.4 Hz, 2H, 
OCH2CH2SH), 3.59 (dd, J = 11.7/4.1 Hz, 1H, OCHCH2O), 3.67 (dd, J = 11.7/7.5 Hz, 
1H, OCHCH2O), 4.44 (dd, J = 7.5/4.1 Hz, 1H, OCHCH2O), 7.34-7.41 (m, 5H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.48–7.54 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR 
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(CD3OD): δ [ppm] =24.9 (1C, OCH2CH2SH), 67.6 (1C, OCHCH2OH), 72.4 (1C, 
OCH2CH2SH), 84.4 (1C, OCHCH2OH), 89.9 (1C, C≡C), 90.2 (1C, C≡C), 97.2 (1C, 
OCH2OCH3), 124.2 (1C, Carom.), 124.6 (1C, Carom.), 128.3 (2C, C-2'4-(phenylethynyl)phenyl, C-
6'4-(phenylethynyl)phenyl), 129.46 (1C, C-4"phenyl), 129.54 (2C, C-3"phenyl, C-5"phenyl), 
132.5 (2C, Carom.), 132.6 (2C, Carom.), 141.2 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-
1] = 3402, 2866, 2558, 1682, 1504, 1443, 1393, 1339, 1177, 1096, 1034, 833, 752, 
691; LCMS (m/z): [M+H]+ calcd for C18H19O2S: 299.1100, found: 299.1131; HPLC 




18 (190 mg, 0.46 mmol) was dissolved in HCl-saturated methanol (5 mL). The reaction 
was stirred at ambient temperature for 16 h. After addition of a saturated aqueous 
solution of sodium bicarbonate and water, the mixture was extracted with ethyl acetate 
(3×). The combined organic layers were dried over sodium sulfate, filtered, and the 
solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 2 cm, h = 15 cm, cyclohexane/ethyl acetate = 3:1 → 1:2, 
V = 10 mL) to give 21 as colorless oil (150 mg, 0.40 mmol, 87 % yield). Rf = 0.21 
(cyclohexane/ethyl acetate = 1:1); specific rotation: [α]$%& = +91.2 (5.5; CH2Cl2); 1H 
NMR (CD2Cl2): δ [ppm] = 2.40-2.48 (m, 1H, OCHCH2OH), 3.05 (s, 3H, OSO2CH3), 
3.59-3.74 (m, 4H, OCH2CH2OS, OCHCH2OH), 4.34-4.41 (m, 2H, OCH2CH2OS), 4.49 
(dd, J = 8.2/3.6 Hz, 1H, OCHCH2O), 7.32-7.35 (m, 2H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-
(phenylethynyl)phenyl), 7.35-7.39 (m, 3H, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.52-7.56 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR (CD2Cl2): 
δ [ppm] = 38.2 (1C, OSO2CH3), 67.56 (1C, OCHCH2O), 67.63 (1C, OCH2CH2OS), 
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69.7 (1C, OCH2CH2OS), 84.2 (1C, OCHCH2O), 89.4 (1C, C≡C), 90.1 (1C, C≡C), 123.6 
(1C, C-1"phenyl), 123.7 (1C, C-4'4-(phenylethynyl)phenyl), 127.6 (2C, C-2'4-(phenylethynyl)phenyl, C-
6'4-(phenylethynyl)phenyl), 129.0 (3C, C-3"phenyl, C-5"phenyl, C-4"phenyl), 132.1 (2C, C-2"phenyl, C-
6"phenyl), 132.3 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 139.0 (1C, C-1'4-
(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 3522, 2924, 1508, 1443, 1346, 1173, 1115, 1015, 
972, 918, 833, 802, 756; LCMS (m/z): [M+H]+ calcd for C19H21O5S: 361.1104, found: 




Triethylamine (90 µL, 65 mg, 0.64 mmol) and thioacetic acid (46 µL, 49 mg, 
0.64 mmol) were added to a solution of 21 (120 mg, 0.32 mmol) in DMF (10 mL). The 
reaction mixture was stirred at ambient temperature overnight. Then water was added 
and the mixture was extracted with ethyl acetate (3×). The combined organic layers 
were dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The 
residue was purified by flash column chromatography (Ø = 2 cm, h = 15 cm, 
cyclohexane/ethyl acetate = 8:2, V = 10 mL) to give 22 as reddish oil (78 mg, 
0.23 mmol, 72 % yield). Rf = 0.33 (cyclohexane/ethyl acetate = 3:1); specific rotation: 
[α]$%& = +109.5 (9.0; CH2Cl2); 1H NMR (CD2Cl2): δ [ppm] = 2.32 (s, 3H, SCOCH3), 3.05-
3.16 (m, 2H, OCH2CH2S), 3.46-3.66 (m, 4H, OCH2CH2S, OCHCH2O), 4.44 (dd, 
J = 7.7/4.2 Hz, 1H, OCHCH2O), 7.30-7.40 (m, 5H, Harom.), 7.50–7.57 (m, 4H, Harom.); 
13C NMR (CD2Cl2): δ [ppm] = 29.7 (1C, OCH2CH2S), 31.0 (1C, SCOCH3), 67.5 (1C, 
OCHCH2O), 68.4 (1C, OCH2CH2S), 83.6 (1C, OCHCH2O), 89.5 (1C, C≡C), 90.0 (1C, 
C≡C), 123.5 (1C, Carom.), 123.7 (1C, Carom.), 127.5 (2C, Carom.), 128.96 (1C, Carom.), 
128.98 (2C, Carom.), 132.1 (2C, Carom.), 132.2 (2C, Carom.), 139.5 (1C, Carom.), 195.8 (1C, 
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SCOCH3); IR (neat): ṽ [cm-1] = 3429, 2866, 1686, 1508, 1393, 1350, 1099, 1042, 953, 
833, 756, 691, 625; LCMS (m/z): [M+H]+ calcd for C20H21O3S: 341.1206, found: 




Potassium phthalimide (840 mg, 4.5 mmol) was added to a solution of 18 (1.7 g, 
4.1 mmol) in DMF (55 mL). The mixture was stirred at 80 °C for 3 h. After cooling the 
reaction mixture to ambient temperature, water was added and the mixture was 
extracted with ethyl acetate (3×). The combined organic layers were dried over sodium 
sulfate, filtered, and the solvent was evaporated in vacuo. The residue was purified by 
flash column chromatography (Ø = 6 cm, h = 15 cm, cyclohexane/ethyl acetate = 8:2 
→ 2:1, V = 50 mL) to give 23 as colorless oil (1.6 g, 3.4 mmol, 84 % yield). Rf = 0.26 
(cyclohexane/ethyl acetate = 3:1); specific rotation: [α]$%& = +7.6 (1.6; CH2Cl2); 1H NMR 
(CD2Cl2): δ [ppm] = 3.18 (s, 3H, OCH2OCH3), 3.53 (dd, J = 10.8/4.3 Hz, 1H, 
OCHCH2O), 3.62-3.70 (m, 3H, OCHCH2O (1H), NCH2CH2O), 3.81 (dt, J = 14.1/5.4 Hz, 
1H, NCH2CH2O), 3.90 (ddd, J = 14.1/7.0/5.2 Hz, 1H, NCH2CH2O), 4.45-4.49 (m, 2H, 
OCHCH2O, OCH2OCH3 (1H)), 4.50 (d, J = 6.5 Hz, 1H, OCH2OCH3), 7.22-7.26 (m, 2H, 
2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl), 7.33–7.41 (m, 5H, C-3'4-(phenylethynyl)phenyl, C-
5'4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.50-7.55 (m, 2H, 2"-Hphenyl, 6"-
Hphenyl), 7.72-7.76 (m, 2H, 5'''-Hisoindoline, 6'''-Hisoindoline), 7.80-7.86 (m, 2H, 4'''-Hisoindoline, 
7'''-Hisoindoline); 13C NMR (CD2Cl2): δ [ppm] = 38.3 (1C, NCH2CH2O), 55.4 (1C, 
OCH2OCH3), 66.5 (1C, NCH2CH2O), 71.7 (1C, OCHCH2O), 81.9 (1C, OCHCH2O), 
89.6 (1C, C≡C), 89.9 (1C, C≡C), 97.1 (1C, OCH2OCH3), 123.3 (1C, C-4'4-
(phenylethynyl)phenyl), 123.6 (2C, C-4'''isoindoline, C-7'''isoindoline), 123.7 (1C, C-1"phenyl), 127.6 
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(2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.9 (1C, C-4"phenyl), 129.0 (2C, C-
3"phenyl, C-5"phenyl), 132.0 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 132.1 (2C, 
C-2"phenyl, C-6"phenyl), 132.7 (2C, C-3a'''isoindoline, C-7a'''isoindoline), 134.5 (2C, C-5'isoindoline, 
C-6'isoindoline), 140.2 (1C, C-1'4-(phenylethynyl)phenyl), 168.6 (2C, C-1'''isoindoline, C-3'''isoindoline); 
IR (neat): ṽ [cm-1] = 2882, 1775, 1709, 1393, 1107, 1030, 918, 837, 756, 718, 691; 
LCMS (m/z): [M+H]+ calcd for C28H26NO5: 456.1805, found: 456.1784; HPLC (method 




An aqueous solution of methylamine (40 % wt., 0.89 mL, 10 mmol) was added to a 
solution of 23 (1.6 g, 3.4 mmol) in absolute ethanol (60 mL). The mixture was heated 
to 70 °C for 16 h. Then water (60 mL) was added, the mixture was acidified (pH < 2) 
with a 1 N aqueous solution of sulfuric acid and extracted with ethyl acetate. 
Afterwards, the water layer was basified (pH > 10) with a 0.5 M aqueous solution of 
sodium hydroxide and extracted with ethyl acetate (3×). The combined organic layers 
were dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The 
residue was purified by flash column chromatography (Ø = 4 cm, h = 15 cm, 
dichloromethane/methanol = 20:1 → 5:1, V = 30 mL) to give 24 as yellowish solid 
(910 mg, 2.8 mmol, 82 % yield).Rf (RP-TLC) = 0.33 (acetonitrile/water = 2:1); melting 
point: 97 °C; specific rotation: [α]$%& = +62.1 (3.3; CH2Cl2); 1H NMR (CD3OD): δ [ppm] = 
3.06-3.14 (m, 1H, H2NCH2CH2O), 3.14-3.21 (m, 1H, H2NCH2CH2O), 3.30 (s, 3H, 
OCH2OCH3), 3.59-3.66 (m, 2H, H2NCH2CH2O), 3.68 (dd, J = 10.8/4.2 Hz, 1H, 
OCHCH2O), 3.79 (dd, J = 10.8/7.4 Hz, 1H, OCHCH2O), 4.63 (dd,  J = 7.4/4.2 Hz , 1H, 
OCHCH2O), 4.65 (s, 2H, OCH2OCH3), 7.34-7.45 (m, 5H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-
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(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.48-7.57 (m, 4H, C-3'4-(phenylethynyl)phenyl, 
C-5'4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR (CD3OD): δ [ppm] = 40.8 (1C, 
H2NCH2CH2O), 55.7 (1C, OCH2OCH3), 66.4 (1C, H2NCH2CH2O), 72.6 (1C, 
OCHCH2O), 82.8 (1C, OCHCH2O), 89.7 (1C, C≡C), 90.6 (1C, C≡C), 97.8 (1C, 
OCH2OCH3), 124.4 (1C, C-1"phenyl), 124.6 (1C, C-4'4-(phenylethynyl)phenyl), 128.4 (2C, C-2'4-
(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 129.6 (3C, C-3"phenyl, C-5"phenyl, C-4"phenyl), 132.5 
(2C, C-2"phenyl, C-6"phenyl), 132.8 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 
140.1 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 2874, 1597, 1508, 1485, 1150, 
1099, 1022, 914, 829, 752, 687; LCMS (m/z): [M+H]+ calcd for C20H24NO3: 326.1751, 
found: 326.1779; HPLC (method 2): tR = 13.7 min, purity 97.6 %. 
 
4.2.16. (S)-2-(2-Aminoethoxy)-2-[4-(phenylethynyl)phenyl]ethan-1-ol (25) 
24 (560 mg, 1.7 mmol) was dissolved in a mixture of HCl-saturated ethanol (6 mL) and 
pure ethanol (9 mL). The reaction mixture was stirred at ambient temperature for 16 h. 
After addition of a saturated aqueous solution of sodium bicarbonate and water, the 
mixture was extracted with ethyl acetate (3×). The combined organic layers were dried 
over sodium sulfate, filtered, and the solvent was removed in vacuo. The residue was 
purified by flash column chromatography (Ø = 3 cm, h = 9 cm, 
dichloromethane/methanol/triethylamine = 9:1:0 → 5:1:0.05, V = 5 mL) to give 25 as 
yellowish solid (200 mg, 0.70 mmol, 41 % yield). Rf  (RP-TLC) = 0.20 
(acetonitrile/water = 1:1); melting point: 72 °C; specific rotation: : [α]$%& = +66.9 (1.5; 
CH3OH); 1H NMR: (CD3OD): δ [ppm] = 2.80 (ddd, J = 13.2/6.9/4.0 Hz, 1H, 
H2NCH2CH2O), 2.85 (ddd, J = 13.2/6.0/3.9 Hz, 1H, H2NCH2CH2O), 3.41 (ddd, 
J = 9.8/6.9/3.9 Hz, 1H, H2NCH2CH2O), 3.48 (ddd, J = 9.8/6.0/4.0 Hz, 1H, 
H2NCH2CH2O), 3.59 (dd, J = 11.8/3.7 Hz, 1H, OCHCH2OH), 3.67 (dd, J = 11.8/7.9 Hz, 
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1H, OCHCH2OH), 4.42 (dd, J = 7.9/3.7 Hz , 1H, OCHCH2OH), 7.33 − 7.39 (m, 5H, 2'-
H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.48 − 7.54 
(m, 4H, 2"-Hphenyl, 6"-Hphenyl, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl); 13C NMR 
(CD3OD): δ [ppm] = 42.3 (1C, H2NCH2CH2O), 67.7 (1C, OCHCH2OH), 71.4 (1C, 
H2NCH2CH2O), 84.6 (1C, OCHCH2OH), 89.9 (1C, C≡C), 90.3 (1C, C≡C), 124.2 
(1C, Carom.), 124.5 (1C, Carom.), 128.2 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 
129.5 (1C, C-4"phenyl), 129.6 (2C, C-3"phenyl, C-5"phenyl), 132.5 (2C, Carom.), 132.6 (2C, 
Carom.), 141.1 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 3453, 3352, 3287, 3040, 
2913, 2851, 1605, 1504, 1443, 1335, 1192, 1177, 1099, 1049, 1015, 964, 910, 887, 
860, 829, 752, 687; LC-MS (m/z): [M+H]+ calcd for C18H20NO2: 282.1489, found: 




Under N2 atmosphere, triethylamine (0.13 mL, 93 mg, 0.92 mmol) and EDCI∙HCl 
(88 mg, 0.46 mmol) were added to a suspension of pyrrole-2-carboxylic acid (26 mg, 
0.23 mmol) and HOBt (47 mg, 0.35 mmol) in dry dichloromethane (2 mL). After stirring 
the reaction mixture for 1 h at ambient temperature, a solution of 24 (150 mg, 
0.46 mmol) in dry dichloromethane (1 mL) was added at 0 °C (ice bath). Afterwards, 
the ice bath was removed and the mixture was stirred at ambient temperature 
overnight. Then a saturated aqueous solution of ammonium chloride and water were 
added and the mixture was extracted with dichloromethane (3×). The combined 
organic layers were dried over sodium sulfate, filtered, and the solvent was removed 
in vacuo. The residue was purified by flash column chromatography (Ø = 2 cm, 
h = 17 cm, cyclohexane/ethyl acetate= 1:2, V = 10 mL) to give 26 as colorless oil 
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(85 mg, 0.20 mmol, 87 % yield). Rf = 0.28 (cyclohexane/ethyl acetate = 1:2); specific 
rotation: [α]$%& = +35.3 (2.6; CH2Cl2); 1H NMR (CDCl3): δ [ppm] = 3.33 (s, 3H, 
OCH2OCH3), 3.50-3.61 (m, 2H, HNCH2CH2O (1H), HNCH2CH2O (1H)), 3.62-3.72 (m, 
3H, HNCH2CH2O (1H), HNCH2CH2O (1H), OCHCH2O (1H)), 3.75 (dd, J = 10.9/8.0 Hz, 
1H, OCHCH2O), 4.55 (dd, J = 8.0/3.6 Hz, 1H, OCHCH2O), 4.68 (d, J = 6.9 Hz 1H, 
OCH2OCH3), 4.70 (d, J = 6.9 Hz 1H, OCH2OCH3), 6.23-6.27 (m, 1H, 4'-Hpyrrole), 6.53-
6.66 (m, 2H, 3'-Hpyrrole, CONH), 6.91-6.94 (m, 1H, 5'-Hpyrrole), 7.29-7.39 (m, 5H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.48-7.56 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl), 9.53 (s br, 1H, 1'-
Hpyrrole); 13C NMR (CDCl3): δ [ppm] = 39.3 (1C, HNCH2CH2O), 55.5 (1C, OCH2OCH3), 
68.4 (1C, HNCH2CH2O), 72.0 (1C, OCHCH2O), 81.8 (1C, OCHCH2O), 89.1 (1C, C≡C), 
89.9 (1C, C≡C), 96.9 (1C, OCH2OCH3), 109.1 (1C, 3'-Cpyrrole), 110.0 (1C, 4'-Cpyrrole), 
121.5 (1C, 5'-Cpyrrole), 123.3 (1C, Carom.), 123.4 (1C, Carom.), 126.1 (1C, 2'-Cpyrrole), 126.9 
(2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.49 (1C, C-4"phenyl), 128.50 
(2C, C-3"phenyl, C-5"phenyl), 131.8 (2C, C-2"phenyl, C-6"phenyl), 132.0 (2C, C-3'4-
(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 139.0 (1C, C-1'4-(phenylethynyl)phenyl), 161.2 (1C, 
CONH); IR (neat): ṽ [cm-1] = 3248, 2928, 1632, 1732, 1558, 1512, 1408, 1312, 1107, 
1034, 833, 752, 691; LCMS (m/z): [M+H]+ calcd for C25H27N2O4: 419.1965, found: 




p-Toluenesulfonic acid monohydrate (16 mg, 0.09 mmol) was added to a solution of 
26 (71 mg, 0.17 mmol) in methanol (2 mL) and the mixture was stirred at ambient 
temperature overnight. Then HCl-saturated methanol (0.5 mL) was added and the 
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reaction mixture was stirred until TLC control indicated completion of the reaction. Then 
a saturated aqueous solution of sodium bicarbonate and water were added and the 
mixture was extracted with ethyl acetate (3×). The combined organic layers were dried 
over sodium sulfate, filtered, and the solvent was removed in vacuo. The residue was 
purified by flash column chromatography (Ø =2 cm, h = 15 cm, ethyl acetate = 100%, 
V = 10 mL) to give 27 as colorless solid (52 mg, 0.14 mmol, 82 % yield). Rf = 0.25 
(ethyl acetate); melting point: 124 °C; specific rotation: [α]$%& = +48.9 (3.0; CH2Cl2); 1H 
NMR: (CDCl3): δ [ppm] = 3.48-3.60 (m, 2H, HNCH2CH2O (1H), HNCH2CH2O (1H)), 
3.60-3.78 (m, 4H, HNCH2CH2O (1H), HNCH2CH2O (1H), OCHCH2OH), 4.48 (dd, 
J = 8.2/3.7 Hz, 1H, OCHCH2OH), 6.21-6.27 (m, 1H, 4'''-Hpyrrole), 6.55-6.72 (m, 2H, 
CONH, 3'''-Hpyrrole), 6.90-6.96 (m, 1H, 5'''-Hpyrrole), 7.25-7.31 (m, 2H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl), 7.31-7.40 (m, 3H, 3"-Hphenyl, 5"-Hphenyl, 4"-
Hphenyl), 7.46-7.57 (m, 4H, 2"-Hphenyl, 6"-Hphenyl, 3'-H4-(phenylethynyl)phenyl, 5'-H4-
(phenylethynyl)phenyl), 9.70 (s, 1H, 1'''-Hpyrrole); 13C NMR (CDCl3): δ [ppm] = 39.5 (1C, 
HNCH2CH2O), 67.3 (1C, OCHCH2OH), 68.6 (1C, HNCH2CH2O), 83.5 (1C, 
OCHCH2OH), 89.0 (1C, C≡C), 90.0 (1C, C≡C), 109.7 (1C, 3'''-Cpyrrole), 110.1 (1C, 
4'''-Cpyrrole), 121.9 (1C, 5'''-Cpyrrole), 123.3 (1C, C-1"phenyl), 123.5 (1C, C-4'4-
(phenylethynyl)phenyl), 125.8 (1C, 2'''-Cpyrrole), 126.9 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-
(phenylethynyl)phenyl), 128.5 (3C, C-3"phenyl, C-5"phenyl, C-4"phenyl), 131.8 (2C, C-2"phenyl, 
C-6"phenyl), 132.0 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 138.6 (1C, C-1'4-
(phenylethynyl)phenyl), 161.6 (1C, CONH); IR (neat): ṽ [cm-1] = 3657, 3291, 2978, 2886, 1620, 
1562, 1516, 1393, 1319, 1250, 1099, 1069, 953, 833, 752, 691; LCMS (m/z): [M+H]+ 
calcd for C23H23N2O3: 375.1703, found: 375.1697; HPLC (method 2): tR = 17.2 min, 






Under N2 atmosphere, triethylamine (40 µL, 28 mg, 0.28 mmol) and methanesulfonyl 
chloride (20 µL, 32 mg, 0.28 mmol) were added to a solution of 24 (45 mg, 0.14 mmol) 
in dry dichloromethane (3 mL). After stirring the reaction mixture at ambient 
temperature for 16 h, water was added and the mixture was extracted with ethyl 
acetate (3×). The combined organic layers were dried over sodium sulfate, filtered, and 
the solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 1 cm, h = 20 cm, dichloromethane/methanol = 98:2, V = 2.5 mL) 
to give 28 as colorless oil (44 mg, 0.11 mmol, 79 % yield). Rf = 0.24 
(dichloromethane/methanol = 99:1); specific rotation: [α]$%& = +40.0 (4.5; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 2.97 (s, 3H, SO2CH3), 3.26-3.39 (m, 2H, HNCH2CH2O), 3.35 
(s, 3H, OCH2OCH3), 3.52 (ddd, J = 10.2/7.1/3.5 Hz, 1H, HNCH2CH2O), 3.62-3.68 (m, 
2H, HNCH2CH2O (1H), OCHCH2O (1H)), 3.72 (dd, J = 11.0/8.0 Hz, 1H, OCHCH2O), 
4.53 (dd, J = 8.0/3.6 Hz, 1H, OCHCH2O), 4.67 (s, 2H, OCH2OCH3), 7.28-7.33 (m, 2H, 
2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl), 7.33-7.38 (m, 3H, 3"-Hphenyl, 5"-Hphenyl, 4"-
Hphenyl), 7.50-7.56 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-
Hphenyl); 13C NMR (CDCl3): δ [ppm] = 40.5 (1C, SO2CH3), 43.3 (1C, HNCH2CH2O), 55.6 
(1C, OCH2OCH3), 68.3 (1C, HNCH2CH2O), 72.1 (1C, OCHCH2O), 82.0 (1C, 
OCHCH2O), 89.0 (1C, C≡C), 90.0 (1C, C≡C), 96.9 (1C, OCH2OCH3), 123.2 (1C, C-
1"phenyl), 123.5 (1C, C-4'4-(phenylethynyl)phenyl), 126.9 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-
(phenylethynyl)phenyl), 128.51 (2C, C-3"phenyl, C-5"phenyl), 128.53 (1C, C-4"phenyl), 131.8 (2C, 
C-2"phenyl, C-6"phenyl), 132.0 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 
138.6 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 3283, 2978, 2882, 1508, 1439, 
1404, 1315, 1150, 1107, 1072, 1030, 976, 837, 756, 691; LCMS (m/z): [M+H]+ calcd 
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28 (52 mg, 0.13 mmol) was dissolved in HCl-saturated methanol (5 mL). The reaction 
was stirred at ambient temperature for 16 h. After addition of a saturated aqueous 
solution of sodium bicarbonate and water, the mixture was extracted with ethyl acetate 
(3×). The combined organic layers were dried over sodium sulfate, filtered, and the 
solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 1 cm, h = 15 cm, cyclohexane/ethyl acetate = 2:1 → 0:1, 
V = 5 mL) to give 29 as colorless oil (39 mg, 0.11 mmol, 85 % yield). Rf = 0.35 
(dichloromethane/methanol = 20:1); specific rotation: [α]$%& = +51.8 (7.0; CH2Cl2); 1H 
NMR (CD3OD): δ [ppm] = 2.97 (s, 3H, SO2CH3), 3.23-3.32 (m, 2H, HNCH2CH2O), 3.47 
(ddd, J = 10.0/6.7/4.2 Hz, 1H, HNCH2CH2O), 3.53 (ddd, J = 10.0/5.9/4.4 Hz, 1H, 
HNCH2CH2O), 3.60 (dd, J = 11.8/3.8 Hz, 1H, OCHCH2O), 3.67 (dd, J = 11.8/7.9 Hz, 
1H, OCHCH2O), 4.45 (dd, J = 7.9/3.8 Hz, 1H, OCHCH2O), 7.33-7.40 (m, 5H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.48-7.54 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR (CD3OD): 
δ [ppm] = 40.2 (1C, SO2CH3), 44.2 (1C, HNCH2CH2O), 67.6 (1C, OCHCH2O), 69.5 
(1C, HNCH2CH2O), 84.7 (1C, OCHCH2O), 89.9 (1C, C≡C), 90.3 (1C, C≡C), 124.3 
(1C, Carom.), 124.5 (1C, Carom.), 128.3 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 
129.5 (1C, C-4"phenyl), 129.6 (2C, C-3"phenyl, C-5"phenyl), 132.5 (2C, Carom.), 132.7 (2C, 
Carom.), 140.7 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 3480, 3287, 2928, 2870, 
1732, 1508, 1439, 1408, 1312, 1150, 1103, 1065, 980, 833, 756, 691; LCMS (m/z): 
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[M+H]+ calcd for C19H22NO4S: 360.1264, found: 360.1268; HPLC (method 1): tR = 




Under N2 atmosphere, triethylamine (60 µL, 44 mg, 0.43 mmol) and 
trifluoromethanesulfonyl chloride (46 µL, 73 mg, 0.43 mmol) were added to a solution 
of 24 (70 mg, 0.22 mmol) in dry dichloromethane (7 mL). After stirring the reaction 
mixture at ambient temperature for 16 h, the solvent was removed in vacuo. Then 
water was added and the mixture was extracted with ethyl acetate (3×). The combined 
organic layers were dried over sodium sulfate, filtered, and the solvent was removed 
in vacuo. The residue was purified by flash column chromatography (Ø = 1 cm, 
h = 20 cm, dichloromethane/ methanol = 98:2, V = 2.5 mL) to give 30 as colorless oil 
(44 mg, 0.10 mmol, 45 % yield). Rf = 0.30 (cyclohexane/ethyl acetate = 3:1); specific 
rotation: [α]$%& = +53.8 (3.5; CH2Cl2); 1H NMR (CDCl3): δ [ppm] = 3.41 (s, 3H, 
OCH2OCH3), 3.44-3.54 (m, 3H, HNCH2CH2O, HNCH2CH2O (1H)), 3.65-3.81 (m, 3H, 
OCHCH2O, HNCH2CH2O (1H)), 4.55 (dd, J = 7.8/4.0 Hz, 1H, OCHCH2O), 4.70 (d, 
J = 6.6 Hz, 1H, OCH2OCH3), 4.73 (d, J = 6.6 Hz, 1H, OCH2OCH3), 6.90 (s br, 1H, 
SO2NH), 7.27-7.32 (m, 2H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl), 7.32-7.39 (m, 
3H, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.50-7.57 (m, 4H, 2"-Hphenyl, 6"-Hphenyl, 3'-H4-
(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl); 13C NMR (CDCl3): δ [ppm] = 44.4 (1C, 
HNCH2CH2O), 55.8 (1C, OCH2OCH3), 68.6 (1C, HNCH2CH2O), 73.0 (1C, OCHCH2O), 
82.8 (1C, OCHCH2O), 88.9 (1C, C≡C), 90.1 (1C, C≡C), 97.3 (1C, OCH2OCH3), 120.0 
(q, J = 321 Hz, 1C, CF3), 123.2 (1C, C-1"phenyl), 123.7 (1C, C-4'4-(phenylethynyl)phenyl), 126.7 
(2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.5 (2C, C-3"phenyl, C-5"phenyl), 128.6 
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(1C, C-4"phenyl), 131.8 (2C, C-2"phenyl, C-6"phenyl), 132.1 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-
(phenylethynyl)phenyl), 138.1 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 3144, 2978, 
2886, 1508, 1443, 1373, 1231, 1188, 1150, 1107, 1030, 968, 833, 756, 691; LCMS 
(m/z): [M+NH4]+ calcd for C21H26F3N2O5S: 475.1509, found: 475.1513; HPLC (method 




30 (58 mg, 0.13mmol) was dissolved in a mixture of HCl-saturated methanol (0.5 mL) 
and pure methanol (1.5 mL). The reaction mixture was stirred at ambient temperature 
for 16 h. After addition of a saturated aqueous solution of sodium bicarbonate and 
water, the mixture was extracted with ethyl acetate (3×). The combined organic layers 
were dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The 
residue was purified by flash column chromatography (Ø = 1 cm, h = 21 cm, 
cyclohexane/ethyl acetate = 2:1, V = 5 mL) to give 31 as colorless oil (33 mg, 
0.08 mmol, 63 % yield). Rf = 0.22 (cyclohexane/ethyl acetate = 2:1); specific rotation: 
[α]$%& = +44.0 (1.4; CH2Cl2); 1H NMR (CDCl3): δ [ppm] = 3.40-3.57 (m, 3H, 
HNCH2CH2O, HNCH2CH2O (1H)), 3.59-3.68 (m, 1H, HNCH2CH2O), 3.72 (dd, J = 
11.8/4.0 Hz, 1H, OCHCH2OH), 3.77 (dd, J = 11.8/7.8 Hz, 1H, OCHCH2OH), 4.51 (dd, 
J = 7.8/4.0 Hz, 1H, OCHCH2OH), 6.86-6.97 (m, 1H, SO2NH), 7.26-7.31 (m, 2H, 2'-H4-
(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl), 7.32-7.39 (m, 3H, 3"-Hphenyl, 5"-Hphenyl, 4"-
Hphenyl), 7.50-7.58 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-
Hphenyl); 13C NMR (CDCl3): δ [ppm] = 44.4 (1C, HNCH2CH2O), 67.3 (1C, OCHCH2OH), 
68.1 (1C, HNCH2CH2O), 83.4 (1C, OCHCH2OH), 88.9 (1C, C≡C), 90.2 (1C, C≡C), 
119.9 (q, J = 321 Hz, 1C, CF3), 123.2 (1C, C-1"phenyl), 123.9 (1C, C-4'4-(phenylethynyl)phenyl), 
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126.9 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.5 (2C, C-3"phenyl, C-5"phenyl), 
128.6 (1C, C-4"phenyl), 131.8 (2C, C-2"phenyl, C-6"phenyl), 132.2 (2C, C-3'4-(phenylethynyl)phenyl, 
C-5'4-(phenylethynyl)phenyl), 137.6 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 3661, 
3314, 2978, 2886, 1508, 1443, 1373, 1227, 1184, 1150, 1111, 1065, 976, 833, 756, 
691; LCMS (m/z): [M+H]+ calcd for C19H19F3NO4S: 414.0981, found: 414.0975; HPLC 




Under N2 atmosphere, triethylamine (40 µL, 26 mg, 0.26 mmol) and p-toluenesulfonyl 
chloride (50 mg, 0.26 mmol) were added to a solution of 24 (43 mg, 0.13 mmol) in dry 
dichloromethane (5 mL). After stirring the reaction mixture at ambient temperature for 
16 h, water was added and the mixture was extracted with dichloromethane (3×). The 
combined organic layers were dried over sodium sulfate, filtered, and the solvent was 
removed in vacuo. The residue was purified by flash column chromatography 
(Ø = 1 cm, h = 15 cm, dichloromethane/methanol = 100:0 → 98:2, V = 2.5 mL) to give 
32 as colorless oil (53 mg, 0.11 mmol, 85 % yield). Rf = 0.28 
(dichloromethane/methanol = 98:2); specific rotation: [α]$%& = +22.3 (1.7; CH2Cl2); 1H 
NMR (CD2Cl2): δ [ppm] = 2.44 (s, 3H, SO2PhCH3), 3.02-3.11 (m, 1H, HNCH2CH2O), 
3.11-3.20 (m, 1H, HNCH2CH2O), 3.31 (s, 3H, OCH2OCH3), 3.37 (ddd, 
J = 10.2/7.3/3.6 Hz, 1H, HNCH2CH2O), 3.49 (ddd, J = 10.2/5.9/3.8 Hz, 1H, 
HNCH2CH2O), 3.58 (dd, J = 10.9/3.9 Hz, 1H, OCHCH2O), 3.65 (dd, J = 10.9/7.8 Hz, 
1H, OCHCH2O), 4.40 (dd, J = 7.8/3.9 Hz, 1H, OCHCH2O), 4.63 (s, 2H, OCH2OCH3), 
5.36 (t, J = 5.9 Hz, 1H, SO2NH), 7.22-7.28 (m, 2H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-
(phenylethynyl)phenyl), 7.31-7.41 (m, 5H, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl, 3'''-H4-
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methylbenzenesulfonamide, 5'''-H4-methylbenzenesulfonamide), 7.48-7.57 (m, 4H, 2"-Hphenyl, 6"-Hphenyl, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl), 7.68-7.74 (m, 2H, 2'''-H4-
methylbenzenesulfonamide, 6'''-H4-methylbenzenesulfonamide); 13C NMR (CD2Cl2): δ [ppm] = 21.8 (1C 
SO2PhCH3), 43.8 (1C, HNCH2CH2O), 55.8 (1C, OCH2OCH3), 68.2 (1C, HNCH2CH2O), 
72.4 (1C, OCHCH2O), 82.2 (1C, OCHCH2O), 89.4 (1C, C≡C), 90.1 (1C, C≡C), 97.3 
(1C, OCH2OCH3), 123.6 (1C, C-4'4-(phenylethynyl)phenyl), 123.7 (1C, C-1"phenyl), 127.4 
(2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 127.5 (2C, C-2'''4-methylbenzenesulfonamide, 
C-6'''4-methylbenzenesulfonamide), 128.99 (1C, C-4"phenyl), 129.00 (2C, C-3"phenyl, C-5"phenyl), 
130.3 (2C, C-3'''4-methylbenzenesulfonamide, C-5'''4-methylbenzenesulfonamide), 132.1 (2C, C-2"phenyl, 
C-6"phenyl), 132.2 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 137.7 (1C, C-1'''4-
methylbenzenesulfonamide), 139.6 (1C, C-1'4-(phenylethynyl)phenyl), 144.1 (1C, C-4'''4-
methylbenzenesulfonamide); IR (neat): ṽ [cm-1] = 3256, 2928, 2878, 1597, 1508, 1443, 1404, 
1327, 1153, 1092, 1030, 961, 814, 756, 691, 660; LCMS (m/z): [M+H]+ calcd for 





32 (42 mg, 0.09 mmol) was dissolved in HCl-saturated methanol (4 mL). The reaction 
was stirred at ambient temperature for 16 h. After addition of a saturated aqueous 
solution of sodium bicarbonate and water, the mixture was extracted with ethyl acetate 
(3×). The combined organic layers were dried over sodium sulfate, filtered, and the 
solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 2 cm, h = 10.5 cm, cyclohexane/ethyl acetate = 2:1→ 1:1, 
V = 10 mL) to give 33 as colorless oil (34 mg, 0.08 mmol, 89 % yield). Rf = 0.17 
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(cyclohexane/ethyl acetate = 2:1); specific rotation: [α]$%& = +52.1 (1.5; CH2Cl2); 1H 
NMR (CD2Cl2): δ [ppm] = 2.26-2.31 (m, 1H, OCHCH2OH), 2.44 (s, 3H, SO2PhCH3), 
3.07-3.13 (m, 1H, HNCH2CH2O), 3.17 (dtd, J = 13.4/6.3/3.6 Hz, 1H, HNCH2CH2O), 
3.39 (ddd, J = 10.2/6.8/3.6 Hz, 1H, HNCH2CH2O), 3.44 (ddd, J = 10.1/6.3/3.8 Hz, 1H, 
HNCH2CH2O), 3.56-3.65 (m, 2H, OCHCH2OH), 4.35 (dd, J = 7.9/3.9 Hz, 1H, 
OCHCH2OH), 5.13 (t, J = 6.1 Hz, 1H, SO2NH), 7.21-7.25 (m, 2H, 2'-H4-(phenylethynyl)phenyl, 
6'-H4-(phenylethynyl)phenyl), 7.32-7.35 (m, 2H, 3'''-H4-methylbenzenesulfonamide, 5'''-H4-
methylbenzenesulfonamide), 7.35-7.40 (m, 3H, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.49-7.52 (m, 
2H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl), 7.52-7.56 (m, 2H, 2"-Hphenyl, 6"-Hphenyl), 
7.70-7.73 (m, 2H, 2'''-H4-methylbenzenesulfonamide, 6'''-H4-methylbenzenesulfonamide); 13C NMR 
(CD2Cl2): δ [ppm] = 21.8 (1C SO2PhCH3), 43.8 (1C, HNCH2CH2O), 67.5 (1C, 
OCHCH2OH), 68.2 (1C, HNCH2CH2O), 83.8 (1C, OCHCH2O), 89.4 (1C, C≡C), 90.2 
(1C, C≡C), 123.6 (1C, C-1"phenyl), 123.7 (1C, C-4'4-(phenylethynyl)phenyl), 127.47 (2C, C-2'4-
(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 127.53 (2C, C-2'''4-methylbenzenesulfonamide, C-6'''4-
methylbenzenesulfonamide), 129.0 (3C, C-3"phenyl, C-5"phenyl, C-4"phenyl), 130.3 (2C, C-3'''4-
methylbenzenesulfonamide, C-5'''4-methylbenzenesulfonamide), 132.1 (2C, C-2"phenyl, C-6"phenyl), 132.3 
(2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 137.6 (1C, C-1'''4-methylbenzenesulfonamide), 
139.2 (1C, C-1'4-(phenylethynyl)phenyl), 144.3 (1C, C-4'''4-methylbenzenesulfonamide); IR (neat): ṽ 
[cm-1] = 3487, 3287, 2924, 2870, 1597, 1504, 1443, 1400, 1323, 1157, 1092, 961, 814, 
756, 691, 660; LCMS (m/z): [M+H]+ calcd for C25H26NO4S: 436.1577, found: 436.1572; 
HPLC (method 1): tR = 22.8 min, purity 98.3 %. 
 
4.2.25. (S)-1-[1-(Allyloxy)-2-(methoxymethoxy)ethyl]-4-bromobenzene (35) 
Under N2 atmosphere, a 1 M solution of LiHMDS in THF (4.8 mL, 4.8 mmol) and 
tetrabutylammonium iodide (150 mg, 0.40 mmol) were added to a solution of 34 (1.0 g, 
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4.0 mmol) in THF (50 mL). Then allyl bromide (0.69 mL, 960 mg, 8.0 mmol) was added 
and the mixture was heated to reflux for 16 h. After cooling the mixture to ambient 
temperature, water was added and the mixture was extracted with ethyl acetate (3×). 
The combined organic layers were dried over sodium sulfate, filtered, and the solvent 
was removed in vacuo. The residue was purified by flash column chromatography 
(Ø = 4 cm, h = 15 cm, cyclohexane/ethyl acetate = 8:2, V = 30 mL) to give 35 as 
colorless oil (760 g, 2.5 mmol, 64 % yield). Rf = 0.17 (cyclohexane/ethyl 
acetate = 20:1); specific rotation: [α]$%& = +58.9 (2.0; CH2Cl2); 1H NMR (CDCl3): δ 
[ppm] = 3.29 (s, 3H, OCH2OCH3), 3.60 (dd, J = 10.8/4.3 Hz, 1H, OCHCH2O), 3.73 (dd, 
J = 10.8/7.3 Hz, 1H, OCHCH2O), 3.87 (ddt, J = 12.8/6.0/1.3 Hz, 1H, OCH2CH=CH2), 
3.98 (ddt, J = 12.8/5.2/1.5 Hz, 1H, OCH2CH=CH2), 4.51 (dd, J = 7.3/4.3 Hz, 1H, 
OCHCH2O), 4.61 (d, J = 6.6 Hz, 1H, OCH2OCH3), 4.64 (d, J = 6.6 Hz, 1H, 
OCH2OCH3), 5.16 (dq, J = 10.4/1.4 Hz, 1H, OCH2CH=CH2), 5.24 (dq, J = 17.2/1.6 Hz, 
1H, OCH2CH=CH2), 5.86-5.93 (m, 1H, OCH2CH=CH2), 7.21-7.25 (m, 2H, 2'-H4-
bromophenyl, 6'-H4-bromophenyl), 7.46-7.50 (m, 2H, 3'-H4-bromophenyl, 5'-H4-bromophenyl); 13C NMR 
(CDCl3): δ [ppm] = 55.4 (1C, OCH2OCH3), 70.1 (1C, OCH2CH=CH2), 71.6 (1C, 
OCHCH2O), 79.9 (1C, OCHCH2O), 96.8 (1C, OCH2OCH3), 117.3 (1C, OCH2CH=CH2), 
122.0 (1C, C-4'4-bromophenyl), 128.9 (2C, C-2'4-bromophenyl, C-6'4-bromophenyl), 131.7 (2C, C-
3'4-bromophenyl, C-5'4-bromophenyl), 134.6 (1C, OCH2CH=CH2), 138.5 (1C, C-1'4-bromophenyl); IR 
(neat): ṽ [cm-1] = 2928, 2882, 1593, 1485, 1404, 1339, 1211, 1150, 1107, 1069, 1038, 
1011, 918, 822; LCMS (m/z): [M+H]+ calcd for C13H1879BrO3: 301.0434, found: 






Under N2 atmosphere, copper(I) iodide (67 mg, 0.35 mmol), 
tetrakis(triphenylphosphine)palladium(0) (280 mg, 0.24 mmol) and phenylacetylene 
(0.36 mL, 340 mg, 3.3 mmol) were added to a solution of 35 (710 mg, 2.4 mmol) in 
triethylamine (15 mL). The mixture was heated to reflux and additional phenylacetylene 
(0.36 mL, 340 mg, 3.3 mmol) was added. After heating the reaction mixture to reflux 
for 16 h, the solvent was evaporated and the residue was purified twice by flash column 
chromatography (1. Ø = 6 cm, h = 15 cm, cyclohexane/ethyl acetate = 20:1, 
V = 30 mL, 2. Ø = 5 cm, h = 15 cm, cyclohexane/ethyl acetate = 100:0 → 20:1, 
V = 30 mL) to give 36 as yellowish oil (650 mg, 2.0 mmol, 86 % yield). Rf = 0.16 
(cyclohexane/ethyl acetate = 20:1); specific rotation: [α]$%& = +52.8 (1.6; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 3.29 (s, 3H, OCH2OCH3), 3.64 (dd, J = 10.8/4.2 Hz, 1H, 
OCHCH2O), 3.76 (dd, J = 10.8/7.3 Hz, 1H, OCHCH2O), 3.89 (ddt, J = 12.8/6.0/1.3 Hz, 
1H, OCH2CH=CH2), 4.01 (ddt, J = 12.8/5.1/1.5 Hz, 1H, OCH2CH=CH2), 4.57 (dd, 
J = 7.3/4.2 Hz, 1H, OCHCH2O), 4.63 (d, J = 6.6 Hz, 1H, OCH2OCH3), 4.66 (d, 
J = 6.6 Hz, 1H, OCH2OCH3), 5.17 (dq, J = 10.4/1.5 Hz, 1H, OCH2CH=CH2), 5.26 (dq, 
J = 17.2/1.7 Hz, 1H, OCH2CH=CH2), 5.87-5.97 (m, 1H, OCH2CH=CH2), 7.32-7.44 (m, 
5H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.50-
7.57 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR 
(CDCl3): δ [ppm] = 55.4 (1C, OCH2OCH3), 70.1 (1C, OCH2CH=CH2), 71.7 (1C, 
OCHCH2O), 80.3 (1C, OCHCH2O), 89.3 (1C, C≡C), 89.7 (1C, C≡C), 96.8 (1C, 
OCH2OCH3), 117.2 (1C, OCH2CH=CH2), 123.1 (1C, Carom.), 123.4 (1C, Carom.), 127.3 
(2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 128.4 (1C, C-4"phenyl), 128.5 (2C, 
C-3"phenyl, C-5"phenyl), 131.76 (2C, Carom.), 131.82 (2C, Carom.), 134.8 (1C, 
OCH2CH=CH2), 139.7 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 2924, 2882, 
1597, 1508, 1485, 1439, 1339, 1211, 1150, 1111, 1038, 918, 833, 756, 691; LCMS 
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(m/z): [M+H]+ calcd for C21H23O3: 323.1642, found: 323.1613; HPLC (method 1): tR = 
25.2 min, purity 71.9 %. 
 
4.2.27. (S)-2-(Allyloxy)-2-[4-(phenylethynyl)phenyl]ethan-1-ol (37) 
36 (620 mg, 1.9 mmol) was suspended in a mixture of HCl-saturated methanol (4 mL) 
and pure methanol (6 mL). The reaction mixture was stirred at ambient temperature 
for 16 h. After addition of a saturated aqueous solution of sodium bicarbonate and 
water, the mixture was extracted with ethyl acetate (3×). The combined organic layers 
were dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The 
residue was purified by flash column chromatography (Ø = 3 cm, h = 15 cm, 
cyclohexane/ethyl acetate = 8:2, V = 20 mL) to give 37 as yellow oil (490 mg, 
1.8 mmol, 91 % yield). Rf = 0.25 (cyclohexane/ethyl acetate = 8:2); specific rotation: 
[α]$%& = +102.7 (2.7; CH2Cl2); 1H NMR (CDCl3): δ [ppm] = 3.64 (dd, J = 11.7/3.8 Hz, 1H, 
OCHCH2OH), 3.70 (dd, J = 11.7/8.4 Hz, 1H, OCHCH2OH), 3.85-3.90 (m, 1H, 
OCH2CH=CH2), 4.00-4.05 (m, 1H, OCH2CH=CH2), 4.50 (dd, J = 8.4/3.8 Hz, 1H, 
OCHCH2OH), 5.19-5.21 (m, 1H, OCH2CH=CH2), 5.25-5.29 (m, 1H, OCH2CH=CH2), 
5.89-5.96 (m, 1H, OCH2CH=CH2), 7.29-7.33 (m, 2H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-
(phenylethynyl)phenyl), 7.33-7.38 (m, 3H, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.51-7.56 (m, 4H, 
3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); 13C NMR 
(CDCl3): δ [ppm] = 67.3 (1C, OCHCH2OH), 70.1 (1C, OCH2CH=CH2), 82.0 (1C, 
OCHCH2OH), 89.1 (1C, C≡C), 89.8 (1C, C≡C), 117.6 (1C, OCH2CH=CH2), 123.29 
(1C, Carom.), 123.30 (1C, Carom.), 127.1 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 
128.48 (1C, C-4"phenyl), 128.50 (2C, C-3"phenyl, C-5"phenyl), 131.8 (2C, C-2"phenyl, 
C-6"phenyl), 132.0 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 134.5 (1C, 
OCH2CH=CH2), 138.9 (1C, C-1'4-(phenylethynyl)phenyl); IR (neat): ṽ [cm-1] = 3426, 2866, 
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1597, 1508, 1408, 1339, 1219, 1096, 1042, 922, 833, 756, 691; HPLC (method 1): tR = 




AD-mix-α (410 mg) was added to a mixture of tert-butyl alcohol (1.5 mL) and water 
(1.5 mL). The mixture was cooled to 0 °C, a solution of 37 (82 mg, 0.29 mmol) in a 
mixture of tert-butyl alcohol (1 mL) and water (1 mL) was added and the reaction 
mixture was stirred at 0 °C for 16 h. Then sodium sulfite (440 mg) was added, the 
mixture was warmed to ambient temperature and stirred for 1 h. Then ethyl acetate 
was added to the reaction mixture and after separation of the layers, the aqueous 
phase was again extracted with ethyl acetate (3×). The combined organic layers were 
dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The crude 
product was purified by flash column chromatography (Ø = 2 cm, h = 10 cm, ethyl 
acetate/methanol = 10:1, V = 10 mL) to give an inseparable mixture of diastereomers 
38 and 39 (8:2) as colorless solid (84 mg, 0.27 mmol, 93 % yield). Rf = 0.36 (ethyl 
acetate/methanol = 10:1); melting point: 111 °C; specific rotation: [α]$%& = +89.6 (2.6; 
CH3OH); 1H NMR (CD3OD): δ [ppm] = 3.35 (dd, J = 9.8/6.8 Hz, 0.9H, 
OCH2CHCH2OH38), 3.44-3.46 (m, 0.2H, OCH2CHCH2OH39), 3.49-3.53 (m, 1.8H, 
OCH2CHCH2OH38 (0.9H), OCH2CHCH2OH38 (0.9H)), 3.56-3.60 (m, 2.1H, 
OCH2CHCH2OH38 (0.9H), OCHCH2OH38 (0.9H), OCHCH2OH39 (0.1H), 
OCH2CHCH2OH39), 3.66 (dd, J = 11.7/7.9 Hz, 0.1H, OCHCH2OH39), 3.67 (dd, 
J = 11.7/8.0 Hz, 0.9H, OCHCH2OH38), 3.77-3.84 (m, 1H, OCH2CHCH2OH), 4.44 (dd, 
J = 7.9/3.7 Hz, 1H, OCHCH2OH), 7.34-7.39 (m, 5H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-
(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.49-7.53 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 
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5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-Hphenyl); ratio of the daistereomers: 38 : 39 = 8 : 2; 
13C NMR (CD3OD): δ [ppm] = 64.3 (0.9C, OCH2CHCH2OH38), 64.4 (0.1C, 
OCH2CHOHCH2OH39), 67.7 (1C, OCHCH2OH), 71.7 (0.1C, OCH2CHCH2OH39), 72.1 
(0.9C, OCH2CHCH2OH38), 72.3 (0.1C, OCH2CHCH2OH39), 72.6 (0.9C, 
OCH2CHCH2OH38), 84.8 (0.1C, OCHCH2OH39), 85.1 (0.9C, OCHCH2OH38), 89.9 (1C, 
C≡C), 90.2 (1C, C≡C), 124.1 (0.1C, Carom.39), 124.2 (0.9C, Carom.38), 124.5 (1C, Carom.), 
128.3 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 129.5 (1C, C-4"phenyl), 129.6 
(2C, C-3"phenyl, C-5"phenyl), 132.5 (2C, Carom.), 132.6 (2C, Carom.), 140.9 (0.9C, C-1'4-
(phenylethynyl)phenyl38), 141.0 (0.1C, C-1'4-(phenylethynyl)phenyl39); ratio of the daistereomers: 38 : 
39 = 8 : 2; IR (neat): ṽ [cm-1] = 3456, 3271, 2905, 2862, 1504, 1443, 1404, 1296, 1219, 
1107, 1038, 1022, 930, 829, 752, 691; HRMS (m/z): [M+H]+ calcd for C19H21O4: 




AD-mix-β (410 mg) was added to a mixture of tert-butyl alcohol (1.5 mL) and water 
(1.5 mL). The mixture was cooled to 0 °C, a solution of 37 (82 mg, 0.29 mmol) in a 
mixture of tert-butyl alcohol (1 mL) and water (1 mL) was added and the reaction 
mixture was stirred at 0 °C for 16 h. Then sodium sulfite (440 mg) was added, the 
mixture was warmed to ambient temperature and stirred for 1 h. Then ethyl acetate 
was added to the reaction mixture and after separation of the layers, the aqueous 
phase was again extracted with ethyl acetate (3×). The combined organic layers were 
dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The crude 
product was purified by flash column chromatography (Ø = 2 cm, h = 10 cm, ethyl 
acetate/methanol = 10:1, V = 10 mL) to give an inseparable mixture of diastereomers 
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39 and 38 (6:4) as colorless solid (81 mg, 0.26 mmol, 90 % yield). Rf = 0.35 (ethyl 
acetate/methanol = 10:1); melting point: 106 °C; specific rotation: [α]$%& = +83.1 (3.8; 
CH3OH); 1H NMR (CD3OD): δ [ppm] = 3.35 (dd, J = 9.8/6.8 Hz, 0.4H, 
OCH2CHCH2OH38), 3.43-3.47 (m, 1.2H, OCH2CHCH2OH39), 3.49-3.53 (m, 0.8H, 
OCH2CHCH2OH38 (0.4H), OCH2CHCH2OH38 (0.4H)), 3.56-3.62 (m, 2.6H, 
OCH2CHCH2OH38 (0.4H), OCHCH2OH38 (0.4H), OCHCH2OH39 (0.6H), 
OCH2CHCH2OH39), 3.66 (dd, J = 11.7/7.9 Hz, 0.6H, OCHCH2OH39), 3.67 (dd, 
J = 11.7/8.0 Hz, 0.4H, OCHCH2OH38), 3.79 (qi, J = 5.3 Hz, 0.6H, OCH2CHCH2OH39), 
3.79-3.84 (m, 0.4H, OCH2CHCH2OH38), 4.44 (dd, J = 7.9/3.7 Hz, 1H, OCHCH2OH), 
7.34-7.39 (m, 5H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl, 3"-Hphenyl, 5"-Hphenyl, 4"-
Hphenyl), 7.49-7.53 (m, 4H, 3'-H4-(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl, 2"-Hphenyl, 6"-
Hphenyl); ratio of the daistereomers: 39 : 38 = 6 : 4; 13C NMR (CD3OD): δ [ppm] = 64.3 
(0.4C, OCH2CHCH2OH38), 64.4 (0.6C, OCH2CHOHCH2OH39), 67.7 (1C, OCHCH2OH), 
71.7 (0.6C, OCH2CHCH2OH39), 72.1 (0.4C, OCH2CHCH2OH38), 72.3 (0.6C, 
OCH2CHCH2OH39), 72.6 (0.4C, OCH2CHCH2OH38), 84.8 (0.6C, OCHCH2OH39), 85.1 
(0.4C, OCHCH2OH38), 89.9 (1C, C≡C), 90.2 (1C, C≡C), 124.1 (0.6C, Carom.39), 124.2 
(0.4C, Carom.38), 124.5 (1C, Carom.), 128.3 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-
(phenylethynyl)phenyl), 129.5 (1C, C-4"phenyl), 129.6 (2C, C-3"phenyl, C-5"phenyl), 132.5 (2C, 
Carom.), 132.6 (2C, Carom.), 140.9 (0.4C, C-1'4-(phenylethynyl)phenyl38), 141.0 (0.6C, C-1'4-
(phenylethynyl)phenyl39); ratio of the daistereomers: 39 : 36 = 6 : 4; IR (neat): ṽ [cm-1] = 3653, 
3318, 2978, 2866, 1597, 1443, 1393, 1238, 1111, 1038, 833, 752, 687; HRMS (m/z): 
[M+H]+ calcd for C19H21O4: 313.1434, found: 313.1415; HPLC (method 2): tR = 15.2 
min, purity 96.9 %. 
 
4.2.30. (S)-3-[1-(4-Bromophenyl)-2-(methoxymethoxy)ethoxy]propan-1-ol (40) 
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Under N2 atmosphere, a 0.5 M solution of 9-borabicyclo[3.3.1]nonane (9-BBN) in THF 
(13.2 mL, 6.6 mmol) was added to a solution of 35 (1.0 g, 3.3 mmol) in THF (50 mL) 
and the mixture was stirred at ambient temperature overnight. Then again a 0.5 M 
solution of 9-BBN in THF (6.6 mL, 3.3 mmol) was added. After 1.5 h, the reaction 
mixture was cooled to -25 °C and methanol (1 mL) was added. After 15 min, 1 M NaOH 
(13.2 mL, 13.2 mmol) was added, whereupon after 15 min H2O2 (30 % in H2O) (3.3 
mL, ~33 mmol) was added. Then the mixture was stirred for 1 h at -25˚C, 1 h at ambient 
temperature and finally heated to 40 °C. After the gas formation had finished, the 
mixture was cooled to ambient temperature, water was added and the mixture was 
extracted with dichloromethane (3×). The combined organic layers were dried over 
sodium sulfate, filtered, and the solvent was removed in vacuo. The residue was 
purified by flash column chromatography (Ø = 4 cm, h = 15 cm, cyclohexane/ethyl 
acetate 8/2 → 1/2, V = 20 mL) to give 40 as colorless oil (1.1 g, 3.3 mmol, 99 % yield). 
Rf = 0.49 (cyclohexane/ethyl acetate = 1:1); specific rotation: [α]$%& = +37.7 (3.6; 
CH2Cl2); 1H NMR (CDCl3): δ [ppm] = 1.83 (quin, J = 5.6 Hz, 2H, OCH2CH2CH2OH), 
3.32 (s, 3H, OCH2OCH3), 3.49 – 3.64 (m, 3H, OCH2CH2CH2OH, OCHCH2O (1H)), 3.67 
(dd, J = 10.7/8.1 Hz 1H, OCHCH2O), 3.79 (m, 2H, OCH2CH2CH2OH), 4.47 (dd, J = 
7.9/3.9 Hz, 1H, OCHCH2O), 4.63 (s, 2H, OCH2OCH3), 7.19 – 7.24 (m, 2H, 2’-H4-
bromophenyl, 6’-H4-bromophenyl), 7.47 – 7.51 (m, 2H, 3’-H4-bromophenyl, 5’-H4-bromophenyl); 13C NMR 
(CDCl3): δ [ppm] = 32.1 (1C, OCH2CH2CH2OH), 55.5 (1C, OCH2OCH3), 62.2 (1C, 
OCH2CH2CH2OH), 68.9 (1C, OCH2CH2CH2OH), 71.7 (1C, OCHCH2O), 81.3 (1C, 
OCHCH2O), 96.8 (1C, OCH2OCH3), 122.2 (1C, C-4‘4-bromophenyl), 128.8 (2C, C-2‘4-
bromophenyl, C-6‘4-bromophenyl), 131.8 (2C, C-3‘4-bromophenyl, C-5‘4-bromophenyl), 138.1 (1C, C-1‘4-
bromophenyl); IR (neat): ṽ [cm-1] = 3433, 2924, 2874, 1589, 1485, 1404, 1339, 1300, 1211, 
1150, 1107, 1069, 1034, 1011, 964, 918, 822; HRMS (m/z): [M+H]+ calc for 
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Under N2 atmosphere, copper(I) iodide (240 mg, 1.3 mmol), 
tetrakis(triphenylphosphine)palladium(0) (420 mg, 0.4 mmol) and phenylacetylene 
(0.8 mL, 740 mg, 7.2 mmol) were added to a solution of 40 (1.1 g, 3.6 mmol) in 
triethylamine (50 mL). The mixture was heated to reflux and another portion of 
phenylacetylene (0.8 mL, 740 mg, 7.2 mmol) was added. After heating the mixture to 
reflux for 16 h, the solvent was evaporated and the residue was purified twice by flash 
column chromatography (1. Ø = 4 cm, h = 15 cm, dichloromethane/methanol 98/2 → 
90/10, V = 20 mL, 2. Ø = 4 cm, h = 15 cm, cyclohexane/ethyl acetate 8/2 → 1/2, V = 
20 mL) to give 41 as yellowish oil (950 mg, 2.8 mmol, 78 % yield). Rf = 0.49 
(cyclohexane/ethyl acetate = 1:1); specific rotation: [α]$%& = +57.2 (3.0; CH2Cl2); 1H 
NMR: (CDCl3): δ [ppm] = 1.83 (quin, J = 5.6 Hz, 2H, OCH2CH2CH2OH), 3.33 (s, 3H, 
OCH2OCH3), 3.51 – 3.68 (m, 3H, OCH2CH2CH2OH, OCHCH2O (1H)), 3.70 (dd, J = 
10.8/8.1 Hz, 1H, OCHCH2O), 3.77 – 3.85 (m, 2H, OCH2CH2CH2OH), 4.53 (dd, J = 
8.0/3.8 Hz, 1H, OCHCH2O), 4.65 (s, 2H, OCH2OCH3), 7.29 – 7.38 (m, 5H, Harom.), 7.51 
– 7.55 (m, 4H, Harom.); 13C NMR (CDCl3): δ [ppm] = 32.1 (1C, OCH2CH2CH2OH), 55.5 
(1C, OCH2OCH3), 62.3 (1C, OCH2CH2CH2OH), 69.0 (1C, OCH2CH2CH2OH), 71.8 (1C, 
OCHCH2O), 81.6 (1C, OCHCH2O), 89.1 (1C, C≡C), 89.8 (1C, C≡C), 96.8 (1C, 
OCH2OCH3), 123.27 (1C, Carom.), 123.28 (1C, Carom.), 127.1 (2C, Carom.), 128.48 (1C, 
Carom.), 128.50 (2C, Carom.), 131.8 (2C, Carom.), 131.9 (2C, Carom.), 139.2 (1C, Carom.); IR 
(neat): ṽ [cm-1] = 3441, 2928, 2882, 1597, 1508, 1443, 1400, 1342, 1211, 1150, 1107, 
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1034, 964, 918, 833, 756, 691; HRMS (m/z): [M+H]+ calc for C21H25O4: 341.1747, 




Under N2 atmosphere, triethylamine (0.65 mL, 0.48 g, 4.7 mmol) and 4-
dimethylaminopyridine (60 mg, 0.50 mmol) were added to a solution of 17 (770 mg, 
2.3 mmol) in dry DCM (50 mL). Then 4-toluenesulfonyl chloride (900 mg, 4.7 mmol) 
was added and the reaction was stirred for 24 h at room temperature. Afterwards, the 
mixture was extracted with EtOAc (3×), the organic phase dried over sodium sulfate, 
filtered, and concentrated in vacuo. The residue was purified by flash column 
chromatography (Ø = 4 cm, h = 15 cm, cyclohexane/ethyl acetate 8/2 → 1/2, V = 10 
mL) to give 42 as colorless oil (970 mg, 2.0 mmol, 86 % yield). Rf = 0.76 
(cyclohexane/ethyl acetate = 2:1); specific rotation: [α]$%& = +15.3 (3.2; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 2.45 (s, 3H, SO3C6H4CH3), 3.27 (s, 3H, OCH2OCH3), 3.55 – 
3.65 (m, 3H, OCH2CH2OS, OCHCH2O (1H)), 3.67 (dd, J = 10.8/7.5 Hz, 1H, 
OCHCH2O), 4.13 – 4.21 (m, 2H, OCH2CH2OS), 4.47 (dd, J = 7.4/4.1 Hz, 1H, 
OCHCH2O), 4.58 (d, J = 6.6 Hz, 1H, OCH2OCH3), 4.61 (d, J = 6.6 Hz, 1H, OCH2OCH3), 
7.23 – 7.26 (m, 2H, Harom.), 7.31 – 7.38 (m, 5H, Harom.), 7.47 – 7.50 (m, 2H, Harom.), 7.52 
– 7.55 (m, 2H, Harom.), 7.75 – 7.79 (m, 2H, Harom.); 13C NMR (CDCl3): δ [ppm] = 21.8 
(1C, SO3C6H4CH3), 55.4 (1C, OCH2OCH3), 66.8 (1C, OCH2CH2OS), 69.3 (1C, 
OCH2CH2OS), 71.5 (1C, OCHCH2O), 81.8 (1C, OCHCH2O), 89.1 (1C, C≡C), 89.9 (1C, 
C≡C), 96.7 (1C, OCH2OCH3), 123.27 (1C, Carom.), 123.28 (1C, Carom.), 127.1 (2C, 
Carom.), 128.1 (2C, Carom.), 128.49 (1C, Carom.), 128.51 (2C, Carom.), 129.9 (2C, Carom.), 
131.8 (2C, Carom.), 131.9 (2C, Carom.), 133.2 (1C, Carom.), 138.9 (1C, Carom.), 144.9 (1C, 
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Carom.); IR (neat): ṽ [cm-1] = 2924, 2882, 1597, 1508, 1443, 1400, 1358, 1177, 1107, 
1018, 918, 814, 756, 691, 664; HRMS (m/z): [M+H]+ calc for C27H29O6S: 481.1679, 




Under N2 atmosphere, triethylamine (0.75 mL, 0.55 g, 5.4 mmol) and 4-
dimethylaminopyridine (66 mg, 0.54 mmol) were added to a solution of 41 (920 mg, 
2.7 mmol) in dry DCM (50 mL). Then 4-toluenesulfonyl chloride (1.0 g, 5.4 mmol) was 
added and the reaction was stirred for 16 h at room temperature. Afterwards, the 
mixture was extracted with EtOAc (3×), the organic phase dried over sodium sulfate, 
filtered, and concentrated in vacuo. The residue was purified by flash column 
chromatography (Ø = 4 cm, h = 15 cm, cyclohexane/ethyl acetate 8/2 → 1/2, V = 10 
mL) to give 43 as yellowish oil (1.1 g, 2.2 mmol, 82 % yield). Rf = 0.62 
(cyclohexane/ethyl acetate = 2:1); specific rotation: [α]$%& = +26.0 (2.2; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 1.87 – 1.98 (m, 2H, OCH2CH2CH2O), 2.45 (s, 3H, 
SO3C6H4CH3), 3.26 (s, 3H, OCH2OCH3), 3.42 (t, J = 6.0 Hz, 2H, OCH2CH2CH2O), 3.57 
(dd, 1H, J = 10.8/4.2 Hz, OCHCH2O), 3.66 (dd, J = 10.8/7.3 Hz, 1H, OCHCH2O), 4.12 
– 4.22 (m, 2H, OCH2CH2CH2O), 4.40 (dd, J = 7.3/4.2 Hz, 1H, OCHCH2O), 4.58 (d, J = 
6.6 Hz, 1H, OCH2OCH3), 4.60 (d, J = 6.6 Hz, 1H, OCH2OCH3), 7.24 – 7.27 (m, 2H, 
Harom.), 7.32 – 7.38 (m, 5H, Harom.), 7.48 – 7.51 (m, 2H, Harom.), 7.52 – 7.55 (m, 2H, 
Harom.), 7.75 – 7.78 (m, 2H, Harom.); 13C NMR (CDCl3): δ [ppm] = 21.8 (1C, 
SO3C6H4CH3), 29.6 (1C, OCH2CH2CH2O), 55.4 (1C, OCH2OCH3), 64.9 (1C, 
OCH2CH2CH2O), 67.7 (1C, OCH2CH2CH2O), 71.5 (1C, OCHCH2O), 81.5 (1C, 
OCHCH2O), 89.2 (1C, C≡C), 89.8 (1C, C≡C), 96.7 (1C, OCH2OCH3), 123.1 (1C, 
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Carom.), 123.3 (1C, Carom.), 127.0 (2C, Carom.), 128.0 (2C, Carom.), 128.46 (1C, Carom.), 
128.50 (2C, Carom.), 130.0 (2C, Carom.), 131.7 (2C, Carom.), 131.8 (2C, Carom.), 133.3 (1C, 
Carom.), 139.5 (1C, Carom.), 144.8 (1C, Carom.); IR (neat): ṽ [cm-1] = 2924, 2878, 1597, 
1508, 1443, 1358, 1177, 1107, 1034, 941, 833, 814, 756, 691, 664; HRMS (m/z): 
[M+H]+ calc for C28H31O6S: 495.1836, found: 495.1891; HPLC (method 1): tR = 25.7 




Sodium azide (880 mg, 14 mmol) was added to a solution of 42 (1.1 g, 2.4 mmol) in 
DMSO (80 mL). The mixture was heated to reflux for 16 h. After cooling the mixture to 
ambient temperature, water was added and the mixture was extracted with ethyl 
acetate (3×). The combined organic layers were dried (Na2SO4), filtered, and the 
solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 4 cm, h = 15 cm, cyclohexane/ethyl acetate 8/2 → 1/2, V = 20 
mL) to give 44 as yellowish oil (770 mg, 2.2 mmol, 92 % yield). Rf = 0.77 
(cyclohexane/ethyl acetate = 2:1); specific rotation: [α]$%& = +1.9 (2.5; CH2Cl2); 1H NMR 
(CDCl3): δ [ppm] = 3.30 (s, 3H, OCH2OCH3), 3.36 (dt, J = 13.2/5.1 Hz, 1H, 
OCH2CH2N3), 3.42 (dt, J = 13.2/5.1 Hz, 1H, OCH2CH2N3), 3.59 (t, J = 5.1 Hz, 2H, 
OCH2CH2N3), 3.65 (dd, J = 10.8/4.2 Hz, 1H, OCHCH2O), 3.78 (dd, J = 10.8/7.4 Hz, 
1H, OCHCH2O), 4.54 (dd, J = 7.4/4.2 Hz, 1H, OCHCH2O), 4.63 (d, J = 6.6 Hz, 1H, 
OCH2OCH3), 4.66 (d, J = 6.6 Hz, 1H, OCH2OCH3), 7.32 – 7.37 (m, 5H, Harom.), 7.51 – 
7.56 (m, 4H, Harom.); 13C NMR (CDCl3): δ [ppm] = 51.0 (1C, OCH2CH2N3), 55.4 (1C, 
OCH2OCH3), 68.3 (1C, OCH2CH2N3), 71.7 (1C, OCHCH2O), 81.9 (1C, OCHCH2O), 
89.2 (1C, C≡C), 89.8 (1C, C≡C), 96.8 (1C, OCH2OCH3), 123.30 (1C, Carom.), 123.32 
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(1C, Carom.), 127.2 (2C, Carom.), 128.48 (1C, Carom.), 128.50 (2C, Carom.), 131.8 (2C, 
Carom.), 131.9 (2C, Carom.), 139.1 (1C, Carom.); IR (neat): ṽ [cm-1] = 2928, 2882, 2102, 
1597, 1508, 1443, 1342, 1285, 1211, 1150, 1107, 1034, 964, 918, 833, 756, 691; 
HRMS (m/z): [M+H]+ calc for C20H22N3O3: 352.1656, found: 352.1656; HPLC (method 




Sodium azide (800 mg, 12 mmol) was added to a solution of 43 (1.1 g, 2.2 mmol) in 
DMSO (80 mL). The mixture was heated to reflux for 16 h. After cooling the mixture to 
ambient temperature, water was added and the mixture was extracted with ethyl 
acetate (3×). The combined organic layers were dried (Na2SO4), filtered, and the 
solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 4 cm, h = 15 cm, cyclohexane/ethyl acetate 8/2 → 1/2, V = 20 
mL) to give 45 as yellowish oil (730 mg, 2.0 mmol, 90 % yield). Rf = 0.66 
(cyclohexane/ethyl acetate = 8:2); specific rotation: [α]$%& = +38.6 (1.9; CH2Cl2); 1H 
NMR (CDCl3): δ [ppm] = 1.77 – 1.94 (m, 2H, OCH2CH2CH2N3), 3.30 (s, 3H, 
OCH2OCH3), 3.35 – 3.48 (m, 2H, OCH2CH2CH2N3), 3.47 (t, J = 6.1 Hz, 2H, 
OCH2CH2CH2N3), 3.62 (dd, J = 10.8/4.1 Hz, 1H, OCHCH2O), 3.74 (dd, J = 10.8/7.4 
Hz, 1H, OCHCH2O), 4.48 (dd, J = 7.5/4.1 Hz, 1H, OCHCH2O), 4.62 (d, J = 6.5 Hz, 1H, 
OCH2OCH3), 4.65 (d, J = 6.5 Hz, 1H, OCH2OCH3), 7.29 – 7.38 (m, 5H, Harom.), 7.50 – 
7.56 (m, 4H, Harom.); 13C NMR (CDCl3): δ [ppm] = 29.4 (1C, OCH2CH2CH2N3), 48.6 (1C, 
OCH2CH2CH2N3), 55.4 (1C, OCH2OCH3), 66.1 (1C, OCH2CH2CH2N3), 71.7 (1C, 
OCHCH2O), 81.6 (1C, OCHCH2O), 89.2 (1C, C≡C), 89.7 (1C, C≡C), 96.7 (1C, 
OCH2OCH3), 123.1 (1C, Carom.), 123.3 (1C, Carom.), 127.1 (2C, Carom.), 128.4 (1C, 
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Carom.), 128.5 (2C, Carom.), 131.7 (2C, Carom.), 131.8 (2C, Carom.), 139.6 (1C, Carom.); IR 
(neat): ṽ [cm-1] = 2928, 2874, 2095, 1597, 1508, 1443, 1400, 1342, 1300, 1261, 1211, 
1150, 1107, 1034, 972, 918, 837, 756, 691; HRMS (m/z): [M+H]+ calc for C21H24N3O3: 
366.1812, found: 366.1819; HPLC (method 1): tR = 25.1 min, purity 97.3%. 
 
4.2.36. 3-(Benzyloxy)-2-methyl-4H-pyran-4-one (47) 
47 was synthesized according to the literature:65  
Potassium carbonate (4.8 g, 35 mmol) and benzyl bromide (1.3 mL, 1.9 g, 11 mmol) 
were added to a solution of 3-hydroxy-2-methyl-4H-pyran-4-one (1.1 g, 8.7 mmol) in 
dry acetonitrile (50 mL). After heating the mixture to reflux for 16 h, water was added 
and the mixture was extracted with ethyl acetate (3×). The combined organic layers 
were dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The 
residue was purified by flash column chromatography (Ø = 4 cm, h = 15 cm, 
cyclohexane/ethyl acetate = 8:2→ 2:1, V = 30 mL) to give 47 as yellowish oil (1.8 g, 
8.3 mmol, 95 % yield). Rf = 0.49 (cyclohexane/ethyl acetate = 1:1); 1H NMR (CDCl3): 
δ [ppm] = 2.11 (s, 3H, CH3), 5.16 (s, 2H, OCH2Ph), 6.50 (d, J = 5.6 Hz, 1H, 
OCH=CHCO), 7.30-7.36 (m, 3H, 3'-Hphenyl, 4'-Hphenyl, 5'-Hphenyl), 7.37-7.40 (m, 2H, 2'-
Hphenyl, 6'-Hphenyl), 7.64 (d, J = 5.6 Hz, 1H, OCH=CHCO); 13C NMR (CDCl3) 
δ [ppm] = 15.0 (1C, CH3), 73.8 (1C, OCH2Ph), 117.0 (1C, OCH=CHCO), 128.5 (1C, 
C-4'phenyl), 128.6 (2C, C-3'phenyl, C-5'phenyl), 129.2 (2C, C-2'phenyl, C-6'phenyl), 136.9 (1C, 
C-1'phenyl), 143.8 (1C, OC=CCH3), 153.8 (1C, OCH=CHCO), 160.6 (1C, OC=CCH3) 
175.3 (1C, OCH=CHCO); IR (neat): ṽ [cm-1] = 3063, 3028, 2959, 2882, 1643, 1574, 
1497, 1427, 1389, 1354, 1250, 1173, 1080, 1026, 972, 914, 829, 748, 702; LCMS 
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(m/z): [M+H]+ calcd for C13H13O3: 217.0859, found: 217.0875; HPLC (method 1): tR = 




Under N2 atmosphere, polymer-bound triphenylphosphine (1.6 mmol/g, 2.0 g, 3.2 
mmol) was added to a solution of 44 (570 mg, 1.6 mmol) in dry THF (50 mL) and the 
reaction was stirred for 72 h at room temperature. Then water (0.5 mL) was added and 
the mixture was filtered through Celite via a Nutsch-type filter. The organic solvent was 
dried over Na2SO4, filtered, and concentrated in vacuo (obtained crude product: 407 
mg). A portion of the crude product (180 mg) was dissolved in water (50 mL) and 47 
(130 mg, 0.58 mmol) was added. The reaction mixture was stirred for 7 d at 140 °C 
and then quenched with a saturated aqueous solution of NH4Cl. After cooling the 
mixture to ambient temperature, it was extracted with ethyl acetate (3×). The combined 
organic layers were dried (Na2SO4), filtered, and the solvent was removed in vacuo. 
The residue was purified by flash column chromatography (Ø = 1 cm, h = 15 cm, 
dichloromethane/methanol 98/2 → 90/10, V = 5 mL) to give 48 as brown solid (71 mg, 
0.14 mmol, 19 % yield). Rf = 0.67 (dichloromethane/methanol = 9:1); melting point: 127 
°C; specific rotation: [α]$%& = +2.8 (c = 1.5; CH2Cl2); 1H NMR (CDCl3): δ [ppm] = 2.12 
(s, 3H, OC=CCH3), 3.28 (s, 3H, OCH2OCH3), 3.50 – 3.55 (m, 2H, OCHCH2O (1H), 
OCH2CH2N (1H)), 3.60 – 3.67 (m, 2H, OCHCH2O (1H), OCH2CH2N (1H)), 3.93 – 4.00 
(m, 1H, OCH2CH2N), 4.06 (ddd, J = 14.9/7.6/3.8 Hz, 1H, OCH2CH2N), 4.42 (dd, J = 
7.8/3.9 Hz, 1H, OCHCH2O), 4.58 (d, J = 6.6 Hz, 1H, OCH2OCH3), 4.59 (d, J = 6.6 Hz, 
1H, OCH2OCH3), 5.17 (d, J = 11.4 Hz, 1H, OCH2C6H5), 5.29 (d, J = 11.4 Hz, 1H, 
OCH2C6H5), 6.58 – 6.66 (m, 1H, NCH=CHCO), 7.06 – 7.09 (m, 2H, Harom.), 7.26 – 7.31 
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(m, 3H, Harom.), 7.32 – 7.37 (m, 4H, NCH=CHCO, Harom.), 7.40 – 7.43 (m, 2H, Harom.), 
7.46 – 7.48 (m, 2H, Harom.), 7.49 – 7.52 (m, 2H, Harom.); 13C NMR (CDCl3): δ [ppm] = 
12.9 (1C, OC=CCH3), 53.5 (1C, OCH2CH2N), 55.4 (1C, OCH2OCH3), 67.7 (1C, 
OCH2CH2N), 71.6 (1C, OCHCH2O), 73.4 (1C, OCH2C6H5), 82.0 (1C, OCHCH2O), 88.9 
(1C, C≡C), 90.2 (1C, C≡C), 96.8 (1C, OCH2OCH3), 116.9 (1C, NCH=CHCO), 123.1 
(1C, Carom.), 123.7 (1C, Carom.), 126.9 (2C, Carom.), 128.2 (1C, Carom.), 128.4 (2C, Carom.), 
128.5 (2C, Carom.), 128.6 (1C, Carom.), 129.2 (2C, Carom.), 131.8 (2C, Carom.), 132.1 (2C, 
Carom.), 137.6 (1C, Carom.), 138.1 (1C, Carom.), 139.3 (1C, NCH=CHCO), 141.9 (1C, 
OC=CCH3), 145.9 (1C, OC=CCH3), 172.9 (1C, NCH=CHCO); IR (neat): ṽ [cm-1] = 
2928, 2882, 1624, 1566, 1508, 1443, 1250, 1215, 1150, 1107, 1030, 968, 918, 833, 
756, 691; HRMS (m/z): [M+H]+ calc for C33H34NO5: 524.2431, found: 524.2455; HPLC 




Under N2 atmosphere, polymer-bound triphenylphosphine (1.6 mmol/g, 2.2 g, 3.6 
mmol) was added to a solution of 45 (650 mg, 1.8 mmol) in dry THF (50 mL) and the 
reaction was stirred for 72 h at room temperature. Then water (0.5 mL) was added and 
the mixture was filtered through Celite via a Nutsch-type filter. The organic solvent was 
dried over Na2SO4, filtered, and concentrated in vacuo (obtained crude product: 330 
mg). A portion of the crude product (180 mg) was dissolved in water (50 mL) and 47 
(120 mg, 0.53 mmol) was added. The reaction mixture was stirred for 7 d at 140 °C. 
Then a saturated aqueous solution of NH4Cl was added. After cooling the mixture to 
ambient temperature, it was extracted with ethyl acetate (3×). The combined organic 
layers were dried (Na2SO4), filtered, and the solvent was removed in vacuo. The 
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residue was purified by flash column chromatography (Ø = 1 cm, h = 15 cm, 
dichloromethane/methanol 98/2 → 90/10, V = 5 mL) to give 49 as yellowish oil (71 mg, 
0.13 mmol, 14 % yield). Rf = 0.69 (dichloromethane/methanol = 9:1); specific rotation: 
[α]$%& = +17.0 (1.6; CH2Cl2); 1H NMR (CDCl3): δ [ppm] = 1.81 – 1.96 (m, 2H, 
OCH2CH2CH2N), 2.17 (s, 3H, OC=CCH3), 3.17 – 3.26 (m, 1H, OCH2CH2CH2N), 3.33 
(s, 3H, OCH2OCH3), 3.35 – 3.43 (m, 1H, OCH2CH2CH2N), 3.61 (dd, J = 10.7/3.6 Hz, 
1H, OCHCH2O), 3.72 (dd, J = 10.7/8.1 Hz, 1H, OCHCH2O), 3.94 – 4.15 (m, 2H, 
OCH2CH2CH2N), 4.42 (dd, J = 8.1/3.6 Hz, 1H, OCHCH2O), 4.64 (d, J = 6.3 Hz, 1H, 
OCH2OCH3), 4.66 (d, J = 6.3 Hz, 1H, OCH2OCH3), 5.24 (s, 2H, OCH2C6H5), 6.81 – 
7.00 (m, 1H, NCH=CHCO), 7.26 – 7.41 (m, 11H, NCH=CHCO, Harom.), 7.49 – 7.58 (m, 
4H, Harom.); 13C NMR (CDCl3): δ [ppm] = 12.7 (1C, OC=CCH3), 30.4 (1C, 
OCH2CH2CH2N), 51.3 (1C, OCH2CH2CH2N), 55.6 (1C, OCH2OCH3), 64.3 (1C, 
OCH2CH2CH2N), 71.7 (1C, OCHCH2O), 73.6 (1C, OCH2C6H5), 81.8 (1C, OCHCH2O), 
88.9 (1C, C≡C), 90.1 (1C, C≡C), 96.8 (1C, OCH2OCH3), 116.5 (1C, NCH=CHCO), 
123.2 (1C, Carom.), 123.6 (1C, Carom.), 127.0 (2C, Carom.), 128.4 (1C, Carom.), 128.48 (2C, 
Carom.), 128.53 (2C, Carom.), 128.6 (1C, Carom.), 129.3 (2C, Carom.), 131.8 (2C, Carom.), 
132.0 (2C, Carom.), 138.7 (1C, Carom.), 139.6 (1C, NCH=CHCO); the signals for 1Carom., 
OC=CCH3, OC=CCH3, NCH=CHCO could not be observed in the spectrum; IR (neat): 
ṽ [cm-1] = 2928, 2882, 1624, 1566, 1497, 1250, 1215, 1150, 1107, 1034, 972, 918, 
833, 756, 694; HRMS (m/z): [M+H]+ calc for C34H36NO5: 538.2588, found: 538.2627; 






48 (60 mg, 0.11 mmol) was dissolved in dry methanol (5 mL) and a saturated solution 
of hydrochloric acid in methanol (1 mL) was added. After stirring the mixture at room 
temperature overnight, the mixture was extracted with EtOAc (3×), the combined 
organic layers were dried over Na2SO4, filtered, and concentrated in vacuo. The crude 
product was dissolved in dry methanol (10 mL) and Pd/C (10 %, 10 mg) was added. 
The mixture was stirred under H2 atmosphere (4 bar) at room temperature for 16 h. 
The catalyst was filtered off (Celite) and the solvent was removed in vacuo. The residue 
was purified by flash column chromatography (Ø = 1 cm, h = 15 cm, 
dichloromethane/methanol 98/2 → 90/10, V = 5 mL) to give 50 as red solid (12 mg, 
0.03 mmol, 27 % yield). Rf = 0.47 (dichloromethane/methanol = 9:1); melting point: 255 
°C (decomposition); specific rotation: [α]$%& = +0.5 (1.2; CH2Cl2); 1H NMR (CD3OD): δ 
[ppm] = 2.34 (s, 3H, HOC=CCH3), 2.83 – 2.89 (m, 4H, PhCH2CH2Ph), 3.40 – 3.65 (m, 
3H, OCHCH2O, OCH2CH2N (1H)), 3.68 – 3.74 (m, 1H, OCH2CH2N), 4.14 – 4.34 (m, 
3H, OCHCH2O, OCH2CH2N), 6.36 – 6.41 (m, 1H, NCH=CHCO), 6.89 – 6.94 (m, 2H, 
Harom.), 7.03 – 7.07 (m, 2H, Harom.), 7.11 – 7.17 (m, 3H, Harom.), 7.19 – 7.25 (m, 2H, 
Harom.), 7.56 – 7.64 (m, 1H, NCH=CHCO); 13C NMR (CD3OD): δ [ppm] = 12.2 (1C, 
HOC=CCH3), 38.7 (1C, PhCH2CH2Ph), 39.0 (1C, PhCH2CH2Ph), 54.8 (1C, 
OCH2CH2N), 67.6 (1C, OCHCH2OH), 68.4 (1C, OCH2CH2N), 84.8 (1C, OCHCH2O), 
112.3 (1C, NCH=CHCO), 126.9 (1C, Carom.), 127.9 (2C, Carom.), 129.3 (2C, Carom.), 
129.5 (2C, Carom.), 129.7 (2C, Carom.), 133.3 (1C, HOC=CCH3), 137.3 (1C, Carom.), 139.9 
(1C, NCH=CHCO), 142.9 (1C, Carom.), 143.2 (1C, Carom.), 147.0 (1C, HOC=CCH3), 
170.8 (1C, NCH=CHCO); IR (neat): ṽ [cm-1] = 3267, 2978, 2920, 1624, 1562, 1504, 
1454, 1346, 1250, 1107, 1072, 822, 748, 698; HRMS (m/z): [M+H]+ calc for C24H28NO4: 






49 (60 mg, 0.11 mmol) was dissolved in dry methanol (5 mL) and a saturated solution 
of hydrochloric acid in methanol (1 mL) was added. After stirring the mixture at room 
temperature overnight, the mixture was extracted with EtOAc (3×). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated in vacuo. The crude 
product was dissolved in dry methanol (10 mL) and Pd/C (10 %, 10 mg) was added. 
The mixture was stirred under H2 atmosphere (4 bar) at room temperature for 16 h. 
The catalyst was filtered off (Celite) and the solvent was removed in vacuo. The residue 
was purified by flash column chromatography (Ø = 1 cm, h = 15 cm, 
dichloromethane/methanol 98/2 → 90/10, V = 5 mL) to give 51 as red solid (12 mg, 
0.03 mmol, 26 % yield). Rf = 0.49 (dichloromethane/methanol = 9:1); specific rotation: 
[α]$%& = +29.3 (1.8; CH2Cl2); 1H NMR (CD3OD): δ [ppm] = 1.90 – 2.06 (m, 2H, 
OCH2CH2CH2N), 2.43 (s, 3H, HOC=CCH3), 2.84 – 2.94 (m, 4H, PhCH2CH2Ph), 3.32 
– 3.35 (m, 1H, OCH2CH2CH2N), 3.36 – 3.41 (m, 1H, OCH2CH2CH2N), 3.56 (dd, J = 
11.7/3.5 Hz, 1H, OCHCH2OH), 3.69 (dd, J = 11.7/8.2 Hz, 1H, OCHCH2OH), 4.12 – 
4.25 (m, 2H, OCH2CH2CH2N), 4.31 (dd, J = 8.2/3.5 Hz, 1H, OCHCH2OH), 6.34 (d, J = 
7.0 Hz, 1H, NCH=CHCO), 7.12 – 7.20 (m, 5H, Harom.), 7.20 – 7.24 (m, 4H, Harom.), 7.59 
(d, J = 7.0 Hz, 1H, NCH=CHCO); 13C NMR (CD3OD): δ [ppm] = 11.9 (1C, HOC=CCH3), 
31.6 (1C, OCH2CH2CH2N), 38.8 (1C, PhCH2CH2Ph), 39.0 (1C, PhCH2CH2Ph), 52.3 
(1C, OCH2CH2CH2N), 65.9 (1C, OCH2CH2CH2N), 67.7 (1C, OCHCH2OH), 84.9 (1C, 
OCHCH2OH), 112.5 (1C, NCH=CHCO), 126.9 (1C, Carom.), 128.1 (2C, Carom.), 129.3 
(2C, Carom.), 129.5 (2C, Carom.), 129.8 (2C, Carom.), 132.9 (1C, OC=CCH3), 137.9 (1C, 
Carom.), 139.2 (1C, NCH=CHCO), 143.0 (1C, Carom.), 143.1 (1C, Carom.), 147.3 (1C, 
HOC=CCH3), 170.5 (1C, NCH=CHCO); IR (neat): ṽ [cm-1] = 3275, 2924, 2859, 1624, 
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1562, 1508, 1346, 1246, 1103, 1038, 822, 748, 698; HRMS (m/z): [M+H]+ calc for 
C25H30NO4: 408.2169, found: 408.2268; HPLC (method 2): tR = 16.0 min, purity 97.8%. 
 
4.2.41. (S)-N-Hydroxy-2-[2-hydroxy-1-(4-phenethylphenyl)ethoxy]acetamide (53) 
52 (53 mg, 0.19 mmol) was dissolved in dry methanol (10 mL) and Pd/C (10 %, 10 mg) 
was added. The mixture was stirred under H2 atmosphere (balloon) at ambient 
temperature for 16 h. Then, the catalyst was filtered off (Celite) and the solvent was 
removed in vacuo. The crude product (50 mg) was dissolved in dry methanol (5 mL) 
and hydroxylamine hydrochloride (38 mg, 0.54 mmol) and a 5.4 M solution of sodium 
methoxide in methanol (0.1 mL, 0.54 mmol) were added. The reaction mixture was 
stirred at ambient temperature for 16 h until TLC showed complete conversion. Then 
the reaction mixture was acidified with 1.0 M HCl and the mixture was extracted with 
ethyl acetate (3×). The combined organic layers were dried (Na2SO4), filtered, and the 
solvent was removed in vacuo. The residue was purified by flash column 
chromatography (Ø = 1 cm, h = 15 cm, dichloromethane/methanol = 98/2 → 90/10, V 
= 5 mL) to give 53 as brown oil (33 mg, 0.10 mmol, 55 % yield). Rf = 0.61 
(dichloromethane/methanol = 9:1); specific rotation: [α]$%& = +66.4 (3.0; CH2Cl2); 1H 
NMR (CD3OD): δ [ppm] = 2.84 – 2.95 (m, 4H, PhCH2CH2Ph), 3.58 (dd, J = 11.9/3.2 
Hz, 1H, OCHCH2OH), 3.69 (dd, J = 11.9/8.4 Hz, 1H, OCHCH2OH), 3.84 (d, J = 14.9 
Hz, 1H, OCH2CONHOH), 3.92 (d, J = 14.9 Hz, 1H, OCH2CONHOH), 4.41 (dd, J = 
8.4/3.2 Hz, 1H, OCHCH2OH), 7.11 – 7.25 (m, 9H, Harom.); 13C NMR (CD3OD): δ [ppm] 
= 38.7 (1C, PhCH2CH2Ph), 39.0 (1C, PhCH2CH2Ph), 67.5 (1C, OCHCH2OH), 68.3 (1C, 
OCH2CONHOH), 85.6 (1C, OCHCH2OH), 126.9 (1C, Carom.), 128.0 (2C, Carom.), 129.3 
(2C, Carom.), 129.5 (2C, Carom.), 129.9 (2C, Carom.), 136.4 (1C, Carom.), 142.9 (1C, Carom.), 
143.5 (1C, Carom.), 169.1 (1C, OCH2CONHOH); IR (neat): ṽ [cm-1] = 2978, 1728, 1670, 
70 
 
1431, 1192, 1130, 1053, 1030, 818, 721, 698; HRMS (m/z): [M+H]+ calc for C18H22NO4: 
316.1543, found: 316.1548; HPLC (method 2): tR = 15.8 min, purity 96.3%. 
 
4.2.42. 3-(Benzyloxy)-1-(4-bromophenethyl)-2-methylpyridin-4(1H)-one (55) 
2-(4-Bromophenyl)ethylamine (210 mg, 1.0 mmol) was added to an emulsion of 47 
(230 mg, 1.0 mmol) in water (5 mL). The reaction mixture was stirred at 140 °C for 
10 d. Afterwards, ethyl acetate was added and after separation of the layers, the 
aqueous phase was extracted with ethyl acetate (2×). The combined organic layers 
were dried over sodium sulfate, filtered, and the solvent was removed in vacuo. The 
residue was purified by flash column chromatography (Ø = 3 cm, h = 15 cm, 
dichloromethane/methanol = 97:3, V = 20 mL) to give 55 as brownish oil (250 mg, 0.62 
mmol, 60 % yield). Rf = 0.29 (dichloromethane/methanol = 10:1); 1H NMR 
(CDCl3): δ [ppm] = 2.03 (s, 3H, OC=CCH3), 2.84 (t, J = 6.8 Hz, 2H, NCH2CH2Ph), 3.95 
(t, J = 6.8 Hz, 2H, NCH2CH2Ph), 5.22 (s, 2H, OCH2Ph), 6.34 (d, J = 7.3 Hz, 1H, 
NCH=CHCO), 6.80 – 6.85 (m, 2H, 2'-H4-bromophenyl, 6'-H4-bromophenyl), 6.90 (d, J = 7.3 Hz, 
1H, NCH=CHCO), 7.28 – 7.35 (m, 3H, 3"-Hbenzyloxy, 4"-Hbenzyloxy, 5"-Hbenzyloxy), 7.37 – 
7.42 (m, 4H, 2"-Hbenzyloxy, 6"-Hbenzyloxy, 3'-H4-bromophenyl, 5'-H4-bromophenyl); 13C NMR 
(CDCl3): δ [ppm] = 12.6 (1C, OC=CCH3), 36.6 (1C, NCH2CH2Ph), 54.9 (1C, 
NCH2CH2Ph), 73.1 (1C, OCH2Ph), 117.3 (1C, NCH=CHCO), 121.5 (1C, C-4'4-
bromophenyl), 128.2 (1C, C-4"benzyloxy), 128.4 (2C, C-3"benzyloxy, C-5"benzyloxy), 129.4 (2C, C-
2"benzyloxy, C-6"benzyloxy), 130.6 (2C, C-2'4-bromophenyl, C-6'4-bromophenyl), 132.3 (2C, C-3'4-
bromophenyl, C-5'4-bromophenyl), 135.3 (1C, C-1'4-bromophenyl), 137.6 (1C, C-1"benzyloxy), 
138.3 (1C, NCH=CHCO), 140.6 (1C, OC=CCH3), 146.2 (1C, OC=CCH3), 173.5 (1C, 
NCH=CHCO); IR (neat): ṽ [cm-1] = 2978, 1701, 1624, 1566, 1524, 1489, 1454, 1400, 
1362, 1246, 1215, 1150, 1069, 1011, 972, 818, 737, 702; HRMS (m/z): [M+H]+ calcd 
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Under N2 atmosphere, copper(I) iodide (10 mg, 0.05 mmol), 
tetrakis(triphenylphosphine)palladium(0) (46 mg, 0.04 mmol) and phenylacetylene 
(54 µL, 50 mg, 0.49 mmol) were added to a solution of 55 (140 mg, 0.35 mmol) in a 
mixture of triethylamine (5 mL) and acetonitrile (2 mL). The mixture was heated to 
reflux and additional phenylacetylene (54 µL, 50 mg, 0.49 mmol) was added. After 
stirring the mixture under reflux conditions for 16 h, the solvent was evaporated and 
the residue was purified by flash column chromatography (Ø = 3 cm, h = 15 cm, ethyl 
acetate/methanol = 10:1, V = 20 mL) to give 56 as brown oil (99 mg, 0.24 mmol, 67 % 
yield). Rf = 0.29 (dichloromethane/methanol = 10:1); 1H NMR (CDCl3): δ [ppm] = 2.04 
(s, 3H, OC=CCH3), 2.90 (t, J = 7.0 Hz, 2H, NCH2CH2Ph), 3.98 (t, J = 7.0 Hz, 2H, 
NCH2CH2Ph), 5.24 (s, 2H, OCH2Ph), 6.37 (d, J = 7.5 Hz, 1H, NCH=CHCO), 6.92 (d, J 
= 7.5 Hz, 1H, NCH=CHCO), 6.93 – 6.96 (m, 2H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-
(phenylethynyl)phenyl), 7.28 – 7.38 (m, 6H, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl, 3'''-Hbenzyloxy, 5'''-
Hbenzyloxy, 4'''-Hbenzyloxy), 7.40 – 7.46 (m, 4H, 2'''-Hbenzyloxy, 6'''-Hbenzyloxy, 3'-H4-
(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl), 7.50 – 7.55 (m, 2H, 2"-Hphenyl, 6"-Hphenyl); 13C 
NMR (CDCl3): δ [ppm] = 12.6 (1C, OC=CCH3), 37.1 (1C, NCH2CH2Ph), 55.0 (1C, 
NCH2CH2Ph), 73.2 (1C, OCH2Ph), 88.8 (1C, C=C), 90.2 (1C, C=C), 117.3 (1C, 
NCH=CHCO), 122.6 (1C, C-4'4-(phenylethynyl)phenyl), 123.2 (1C, C-1"phenyl), 128.2 (1C, C-
4'''benzyloxy), 128.4 (2C, C-3'''benzyloxy, C-5'''benzyloxy), 128.5 (2C, C-3"phenyl, C-5"phenyl), 
128.6 (1C, C-4"phenyl), 129.0 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-(phenylethynyl)phenyl), 129.4 
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(2C, C-2'''benzyloxy, C-6'''benzyloxy), 131.7 (2C, C-2"phenyl, C-6"phenyl), 132.3 (2C, C-3'4-
(phenylethynyl)phenyl, C-5'4-(phenylethynyl)phenyl), 136.5 (1C, C-1'4-(phenylethynyl)phenyl), 137.6 (1C, C-
1'''benzyloxy), 138.4 (1C, NCH=CHCO), 140.7 (1C, OC=CCH3), 146.2 (1C, OC=CCH3), 
173.5 (1C, NCH=CHCO); IR (neat): ṽ [cm-1] = 2978, 2886, 1732, 1624, 1562, 1508, 
1497, 1454, 1369, 1242, 1215, 1153, 1069, 968, 826, 752, 691; HRMS (m/z): [M+H]+ 
calcd for C29H26NO2: 420.1958, found: 420.1961; HPLC (method 1): tR = 22.8 min, 
purity 97.9 %. 
 
4.2.44. 3-Hydroxy-2-methyl-1-[4-(phenylethynyl)phenethyl]pyridin-4(1H)-one (57) 
An emulsion of 56 (87 mg, 0.21 mmol) in a 6 M aqueous solution of hydrochloric acid 
(7.5 mL) and methanol (2 mL) was heated to reflux for 4 h. Then the reaction mixture 
was cooled to ambient temperature, a saturated aqueous solution of potassium 
carbonate was added, and the mixture was extracted with ethyl acetate (3×). The 
combined organic layers were washed with a saturated aqueous solution of NaHCO3 
and brine, dried over sodium sulfate, filtered, and the solvent was removed in vacuo. 
The residue was purified by flash column chromatography (Ø = 1 cm, h = 15 cm, 
cyclohexane/ ethyl acetate = 1:2 → 0:1 → ethyl acetate/methanol = 10:1 → 10:1 + 
0.1 % triethylamine, V = 5 mL) to give 57 as yellowish solid (43 mg, 0.13 mmol, 60 % 
yield). Rf = 0.21 (ethyl acetate/methanol = 10:1); melting point = 212 °C 
(decomposition); 1H NMR (DMSO-d6): δ [ppm] = 2.27 (s, 3H, OC=CCH3), 3.00 (t, J = 
7.3 Hz, 2H, NCH2CH2Ph), 4.17 (t, J = 7.3 Hz, 2H, NCH2CH2Ph), 6.04 (d, J = 7.3 Hz, 
1H, NCH=CHCO), 7.24 – 7.29 (m, 2H, 2'-H4-(phenylethynyl)phenyl, 6'-H4-(phenylethynyl)phenyl), 7.40 
– 7.45 (m, 4H, NCH=CHCO, 3"-Hphenyl, 5"-Hphenyl, 4"-Hphenyl), 7.46 – 7.51 (m, 2H, 3'-H4-
(phenylethynyl)phenyl, 5'-H4-(phenylethynyl)phenyl), 7.52 – 7.57 (m, 2H, 2"-Hphenyl, 6"-Hphenyl); 13C 
NMR (DMSO-d6): δ [ppm] = 11.3 (1C, OC=CCH3), 36.1 (1C, NCH2CH2Ph), 53.5 (1C, 
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NCH2CH2Ph), 89.2 (2C, C=C), 110.4 (1C, NCH=CHCO), 120.5 (1C, C-4'4-
(phenylethynyl)phenyl), 122.3 (1C, C-1"phenyl), 128.4 (1C, OC=CCH3), 128.71 (1C, C-4"phenyl), 
128.73 (2C, C-3"phenyl, C-5"phenyl), 129.5 (2C, C-2'4-(phenylethynyl)phenyl, C-6'4-
(phenylethynyl)phenyl) 131.3 (2C, C-2"phenyl, C-6"phenyl), 131.4 (2C, C-3'4-(phenylethynyl)phenyl, C-5'4-
(phenylethynyl)phenyl), 137.5 (1C, NCH=CHCO), 138.4 (1C, C-1'4-(phenylethynyl)phenyl), 145.4 (1C, 
HOC=CCH3), 168.9 (1C, NCH=CHCO); IR (neat): ṽ [cm-1] = 3653, 3136, 2978, 2889, 
1624, 1574, 1531, 1508, 1443, 1381, 1346, 1265, 1223, 1184, 1157, 1061, 1042, 953, 
818, 756, 691; HRMS (m/z): [M+H]+ calcd for C22H20NO2: 330.1489, found: 330.1502; 
HPLC (method 1): tR = 27.0 min, purity 99.5 % (tailing). 
 
4.3. Metabolism studies 
4.3.1. In silico prediction of metabolism 
Sites of metabolism were predicted with FAME 246 with default settings. SyGMa was 
executed via a KNIME66 node available within the 3D-e-Chem virtual machine.67-68 
The number of phase 1 and phase 2 cycles were each set to “1”. 
 
4.3.2. In vitro metabolism studies with rat liver microsome suspensions 
4.3.2.1. Chemicals and materials 
Double distilled water for HPLC and for the preparation of buffer solutions was 
generated by a Milli-Q Advantage Ultrapure Water System, Millipore (Billerica, MA, 
USA). Magnesium chloride hexahydrate was purchased from Honeywell Riedel-de 
Haën (Seelze, Germany). Acetonirtrile in LC-MS grade was obtained from Thermo 
Fischer Scientific (Schwerte, Germany). NADPH tetra sodium salt was purchased from 
Carl Roth (Karlsruhe, Germany). Formic acid p.a. was obtained from Acros Organics 
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(Thermo Fischer Scientific). Phosphate buffer saline tablets, uridine 5´-
diphospoglucoronic acid trisodium salt (UDGPA), Coomassive Brilliant Blue G® and 
methanol in LC-MS grade were purchased from Sigma-Aldrich (Munich, Germany).  
 
4.3.2.2. Preparation of rat liver microsomes  
Deep frozen livers of rats were obtained from the working group of Prof. Dr. M. Düfer, 
Institute of Pharmaceutical and Medicinal Chemistry, Münster, Germany.  
Livers (20 g) were thawed in 1.15 % (m/V) potassium chloride solution at 4 °C. Livers 
were cut in slices and homogenized in an Elvehjem-Potter (10 strokes, 3 sec.) with 20 
mL of cold phosphate buffer (pH 7.4, 0.1 M) containing sodium EDTA (0.5 mM). 60 mL 
of cold sodium phosphate buffer (pH 7.4, 0.1 M) was added and the resulting 
suspension centrifuged for 20 min at 4 °C at 9,000 g. The supernatant was centrifuged 
at 45,000 g for 90 min. The resulting microsome pallet was resolved in sodium 
phosphate buffer (pH 7.4, 0.1 M). Aliquots were stored at -80 °C prior to use.  
 
4.3.2.3. Determination of protein concentration69  
Bradford solution:  
5 mg Coomassie® Brilliant Blue G 250 was dissolved in 2.5 mL abs. ethanol. 10 mL 
dist. water and 5 mL of phosphoric acid were added. The solution was diluted with dist. 
water to 50 mL. The resulting solution was stored in the dark and at 4 °C overnight. 




A stock solution of BSA in dist. water (1.25 mg/mL) was prepared. A multi-point 
calibration curve (19.5 μg, 39 μg, 78 μg, 156μg, 312 μg, 615 μg, 1000 μg all of them 
per mL) was created by dilution of the stock solution with dist. water. The samples 
where diluted 20-fold (50 μL microsome solution, 200 μL 1 M NaOH, 750 μL dist. water) 
and 50-fold (20 μL microsome solution, 200 μL 1 M NaOH, 780 μL dist. water). The 
measurements were performed in a 96-well plate. To 10 μL of a diluted sample and 
each of the calibration solutions, 190 μL Bradford solution were added, respectively. 
The plate was shaken for 5 min and the absorption at 595 nm was recorded. Samples 
and calibration were prepared in triplicate.  
 
4.3.2.4. Incubation of 3 with rat liver microsomes and cofactors 
A stock solution of hydroxamic acid 3 in DMSO (1.0 μL, 10 mM) was added to a 
solution that contained PBS (pH 7.4, 23 μL, 0.1 M), MgCl2 solution (50 μL, 50 mM), 
NADPH solution (50 µL, 2 mg/mL in PBS), UDPGA solution (50 µL, 2 mg/mL in PBS), 
and rat liver microsome suspension (26 μL, 7.8 mg protein/mL). The experiments were 
performed in duplicate. In case of the incubation without UDPGA or NADPH, 50 µL 
PBS was added instead of the solution of the respective cofactor. The resulting 
suspensions were mixed vigorously and shaken for 120 min at 37 °C (900 rpm). The 
incubation was stopped by the addition of ice-cold acetonitrile/methanol (1:1, 400 µL). 
The Eppendorf cups were cooled to 0 °C for 10 min using a water/ice bath. The 
precipitated proteins were separated via centrifugation (15 min, 16000 rpm, 4 °C) and 
the supernatant was analyzed by the LC-MS method described below in positive and 
negative ion polarity. With the same procedure, the empty value (without stock 
solution), the blank value (without cofactors) were prepared. To detect possible 
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impurities in the stock solution, a positive control (599 µL solvent and 1 µL DMSO stock 
solution) was prepared and analyzed by the LC-MS method immediately. 
 
4.3.2.5. HPLC-ESI-MS with micrOTOF-Q II (HPLC method 3) 
For the determination of exact masses, an Ultimate 3000 RS LC system from Dionex 
(Dionex Softron, Bremen, Germany) was coupled with a microOTOF-Q II (Bruker 
Daltonics, Bremen, Germany). The MS was operated with the standard ESI-source. 
The LC system consisted of a solvent rack (SRD 3600), a pump (DGP-3600RS), an 
autosampler (WPS-3000RS), a column oven (TCC-3000RS) and a DAD-dectector 
(DAD-3000RS) operating at 230 and 250 nm. Control of the system and data handling 
were carried out using the software Hystar and DataAnalysis from Bruker Daltonics 
(Bremen, Germany). The calibration of the TOF spectra was achieved by injection of 
10 mM lithium formiate (isopropyl alcohol/bidist. water = 1:1) via a 20 μL sample loop 
within each LC run at 1 min. Precolumn: Security GuardTM Cartidge C18 (4.0 x 2.0 
mm, 4 μm particle size); main column: Phenomenex Synergi Hydro RP (50 x 2.10 mm, 
2.6 μm particle size); solvents: A: bidist. water/acetonitrile = 90:10 with 0.1% formic 
acid (V/V), B: bidist. water/acetonitrile = 10:90 with 0.1% formic acid (V/V); gradient 
elution: (A %): 0 – 5 min: gradient from 100 % to 0 %, 5 – 6.5 min: 0 %, 6.5 – 7 min: 
gradient from 0 % to 100 %, 7 – 10 min: 100 %; flow: 0.4 mL; temperature: 25 °C. 
 
4.3.2.6. Metabolite identification 
3: HRMS (m/z): [M+Na]+ calc for C18H17NO4Na: 334.1050, found: 334.1023; [M-H]- calc 
for C18H16NO4: 310.1085, found: 310.1091; HPLC (method 3): tR = 5.6 min. 
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3+Glu: HRMS (m/z): [M+Na]+ calc for C24H25NO10Na: 519.1371, found: 510.1331; [M-
H]- calc for C24H24NO10: 486.1406, found: 486.1414; HPLC (method 3): tR = 5.4 min. 
3-NH: HRMS (m/z): [M+Na]+ calc for C18H16O4Na: 319.0941, found: 319.0905; [M-H]- 
calc for C18H15NO4: 295.0976, found: 295.0991; HPLC (method 3): tR = 6.1 min. 
 
4.4. Biological evaluation  
4.4.1. Agar diffusion clearance assay  
The antibiotic activity of the synthesized inhibitors was determined by agar disc 
diffusion clearance assays. Liquid cultures of E. coli BL21 (DE3) and the defective 
strain E. coli strain D2261 were grown overnight in LB broth70 at 37 °C, 200 rpm. 150 
μL of an overnight cell suspension were spread evenly onto LB agar petri dishes. 15 
μL of each compound (10 mM in DMSO) were applied onto circular filter paper (Ø = 6 
mm, thickness 0.75 mm, Carl Roth). Pure DMSO, serving as a negative and CHIR-
090,71 serving as a positive control were also spotted. The petri dishes were incubated 
overnight at 37 °C and the diameter of the zone of growth inhibition was measured for 
each compound. 
 
4.4.2. Minimum Inhibitory Concentration (MIC) determination  
The MIC values of the compounds were determined by means of the microdilution 
method using a 96-well plate and LB medium in the presence of 5% DMSO as 
previously reported by Tangherlini et al.72 E. coli BL21 (DE3) and E. coli D22 were 
grown overnight in LB medium at 37 °C and 200 rpm. The overnight suspension was 
diluted 1:100 in fresh LB broth and 190 μL of the inoculated medium were dispensed 
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to each well of a 96-well plate. 10 μL of a twofold dilution series of the compounds in 
DMSO (ranging from 1.28 mg/mL to 1.25 μg/mL) was added to the inoculated medium 
resulting in a final concentration range between 64 μg/mL to 62.5 ng/mL. Then the 
plates were incubated for 20 h at 37 °C and 200 rpm. The lowest concentrations at 
which no visible growth of bacteria could be observed were taken as the MIC values.72 
 
4.4.3. LpxC assay 
The expression and purification of E. coli LpxCC63A was performed as previously 
described.72 A fluorescence-based microplate assay for LpxC activity was performed 
as described by Clements et al.62 The wells in a black, non-binding, 96 wells 
fluorescence microplate (Greiner Bio One, Frickenhausen) were filled with 93 µL of a 
40 mM sodium morpholinoethanesulfonic acid buffer (pH 6.0) containing 26.9 µm UDP-
3-O-[(R)-3-hydroxymyristoyl]-N-acetylglucosamine, 80 µM dithiothreitol and 0.02% Brij 
35. Inhibitors were dissolved in DMSO and assayed over a range starting from 0.2 nM 
up to 200 µM. After addition of 250 ng purified LpxC, the microplate was incubated for 
30 min at 37 °C in a plate shaker. Then the biochemical reaction was stopped by 
adding 40 µL of 0.625 M sodium hydroxide. The reaction mixture was further incubated 
for 10 min and neutralized by adding 40 µL of 0.625 M acetic acid. The deacetylated 
product UDP-3-O-[(R)-3-hydroxymyristoyl]glucosamine was converted into a 
fluorescing isoindole by adding 120 µL of 250 nM o-phthaldialdehyde-2-
mercaptoethanol in 0.1 M borax73 and detected by a Mithras plate reader (Berthold, 
Bad Wildbad) at 340 nm excitation and 460 nm emission wavelengths. The calculation 
of the IC50 values was performed with the aid of the software GraphPadPrism, which 
were then converted into Ki values using the Cheng-Prusoff equation. The Ki and IC50 
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values are given as mean value ± SD from three independent experiments. The KM 
value was calculated from the Lineweaver-Burk plot.  
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